The Global Stem Cells Market is expected to grow from USD 115.46 Million in 2018 to USD 325.84 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 15.97%.

The Stem Cells Market research presents a study by combining primary as well as secondary research. The report gives insights on the key factors concerned with generating and limiting Stem Cells market growth.

Additionally, the report also studies competitive developments, such as mergers and acquisitions, new partnerships, new contracts, and new product developments in the global Stem Cells market. The past trends and future prospects included in this report makes it highly comprehensible for the analysis of the market. Moreover, the latest trends, product portfolio, demographics, geographical segmentation, and regulatory framework of the Stem Cells market have also been included in the study.

Request a Sample Copy of the Report https://www.regalintelligence.com/request-sample/23796

Stem Cells Market Segment by Manufacturers includes: The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Stem Cells Market including are Anterogen Co., Ltd., Holostem Terapie Avanzate Srl, Medipost Co., Ltd., Osiris Therapeutics, Inc., Pharmicell Co., Ltd., Allosource, JCR Pharmaceuticals Co., Ltd., Nuvasive, Inc., and RTI Surgical, Inc.. On the basis of Cell Source, the Global Stem Cells Market is studied across Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, and Cord Blood/Embryonic Stem Cells.On the basis of Type, the Global Stem Cells Market is studied across Allogeneic Stem Cell Therapy and Autologous.On the basis of Therapeutic Application , the Global Stem Cells Market is studied across Cardiovascular Diseases, Gastrointestinal Diseases, Musculoskeletal Disorders, Surgeries, and Wounds and Injuries.

Global Stem Cells market report covers all the major participants and the retailers will be in conscious of the development factors, market barriers & threats, and the opportunities that the market will offer in the near future. The report also features the historical revenue of the market; industry trends, market volume, and consumption in order to gain perceptions about the political and technical environment of the Stem Cells market share.

This report focuses on the Stem Cells in Global market, especially in

Enquire or share your questions if any before the purchasing this report https://www.regalintelligence.com/enquiry/23796

The report gives detailed analysis in terms of qualitative and quantitative data pertaining to the projected potential opportunities that influence markets growth for the forecast period. With a major focus on the key elements and segments of the global Stem Cells market that might affect the growth prospects of the market, making it a highly informative document.

Major Points covered in this Report:

Market Segmentation:

Regional market analysis

The content of the study subjects includes a total of 15 chapters:

Ask For Table of Contents: https://www.regalintelligence.com/request-toc/23796

About Us:We, Regal Intelligence, aim to change the dynamics of market research backed by quality data. Our analysts validate data with exclusive qualitative and analytics driven intelligence. We meticulously plan our research process and execute in order to explore the potential market for getting insightful details. Our prime focus is to provide reliable data based on public surveys using data analytics techniques. If you have come here, you might be interested in highly reliable data driven market insights for your product/service,reach us here 24/7.

Contact Us:Regal Intelligencewww.regalintelligence.comsales@regalintelligence.comPh no: +1 231 930 2779 (U.S.)

Follow Us:https://in.linkedin.com/company/regal-intelligencehttps://www.facebook.com/regalintelligence/https://twitter.com/RI_insights

q

Originally posted here:
Stem Cells Market Top Impacting Factors to Growth of the Industry by 2025 - Bandera County Courier

Recommendation and review posted by Bethany Smith

Co-founders Ravina Anand (left) and Michelle Kwok (right), Mar. 5, 2020.

Men dont know how hard it is to be the only woman at a board meeting. After all, according to FLIKs website, less than one in five businesses globally are led by women.

Thats why current third-year medical science student at Western University, Michelle Kwok, co-founded the Female Laboratory of Innovative Knowledge, a network that connects female students with women in leadership.

The portal launched in January and is still in its beta phase. But as a cost-free service, FLIK has brought together over 100 apprenticeships in a wide range of industries like consulting, technology, marketing, fashion and product design. And, its closing in on 1,000 users.

They currently have students completing apprenticeships at companies like The Gist, Greenpeace and The Fashion Innovation Centre.

High profile women in leadership, like Kim Kaupe co-founder and CEO of The Superfan Company, who regularly works with Justin Bieber, A$AP Rocky and John Mayer are also on the platform.

Our main goal is to create meaningful relationships between the female founders of today and the female founders of tomorrow and together increase female ventures on a global scale, Kwok says.

For students looking for opportunities in their careers, this platform offers them a connection to founders who are seeking new, young hires with fresh and innovative eyes.

Its a win-win proposition, she says.

Starting off as a media company that wanted to showcase female founders career stories, Kwok and her co-founder, Ravina Anand, realized they could do even more. So, they began connecting female founders with people in their student networks.

Fourth-year genetics student Sarah Whittaker is doing a three-month apprenticeship with Louise Macnab, the co-founder and business manager at Moxie a digestive health start-up based in New York.

The beauty of FLIKs apprenticeship model is that its more of a partnership than a job, says Whittaker.

Alongside their mentor, students can create their own projects based on something that would be meaningful for them.

Applicants fill out a profile online, indicating the skills they want to learn and their desired industry, which helps students connect to the best-suited mentor. Mentors can also be requested on a case-by-case basis.

First-year BMOS student Maggie Chen joined FLIK because she wanted to connect with a female CEO or founder on a personal level instead, she found two.

Through FLIK, Chen said shes seen the impact a female-led organization can have on a community.

As a young woman trying to navigate your way into the entrepreneurial or innovative world, you face so many barriers and challenges, says Kwok.

Chen has seen the struggles of being a woman in business. She thinks a lot of young, female students are insecure about their capabilities when they compare themselves to their male counterparts.

FLIK has shown Chen how a small group of women can do so much change by bringing together a community of female leaders across Canada.

Kwok says having female mentors herself helped her with her self-confidence in building her platform.

Business doesnt just have to be for men, she says. If we dont try or leap off the bridge like all these other guys then were never going to equal the playing field.

The young founder believes women need to support each other now because its a critical time when women are going to completely shift gears, become entrepreneurs and change the economy.

Its going to be easier if we have people who look like us alongside us and supporting us, she says.

See the original post here:
Student startup connecting the female founders of today and tomorrow - The Gazette Western University's Newspaper

Recommendation and review posted by Bethany Smith

Though the Louisiana legislative session doesnt begin until Monday, a bill that would mandate transgender student athletes participate in team sports corresponding to their sex assigned at birth, rather than their gender identity, is already garnering attention.

The bill by Rep. Beryl Amedee, a Houma Republican, would apply to sports teams at Louisiana public schools and private schools that receive public funds such as through voucher programs from the elementary school level through the collegiate level. A similar bill has also been pre-filed by Sen. Beth Mizell, a Franklinton Republican.

Amedee said the bill would not ban transgender athletes from sports but rather level the playing field for athletes assigned female at birth because transgender females are generally, stereotypically speaking, at an advantage over biological females. She said that on average men have greater average lung volume, larger bones and muscles than women.

An athlete who truly wants to compete because of the love of the sport is going to want to compete where the competition is fair, she said, and the competition is fair when it's based appropriately on your makeup. If you are biologically male, but you compete against the females, how can you ever be assured that your win is truly a win?

Opponents of the law say there are many different body types within sexes and argue that a law shouldnt be made based on generalizations.

Certainly, that does not apply across the board, and that I think is what makes this such an unfair and ridiculous piece of legislation, said Brandon Robb, a lawyer at a New Orleans law firm that works with many LGBT clients. You could take individuals, even people who were female from birth and still are biologically female Some women are going to be taller, stronger than other women.

It would exclude people based on a broad generalization, he continued. Gender discrimination based on that sort of broad generalization, I think is going to be really suspect to a court of law that might be reviewing it (in the future).

White evangelical Protestants stand noticeably apart from other religious people in a new poll.

While Amedee said she has not heard of specific situations in Louisiana where transgender female athletes were systematically outperforming those assigned female at birth, she said it was important to get ahead of the issue.

I think if we don't take care of this, if this becomes an issue in Louisiana where we have a lot of athletic competitions where we have biological females competing against transgender females and the competition becomes unfair, as it has in other places in this country, then what we're going to see is the demise of women's sports, she said. We'll see women just not bothering, and to me, that's a step backwards.

More than a dozen other states, including Ohio, Idaho and Missouri, have filed similar bills in recent months regarding transgender students participation in sports, legislation often dubbed the Save Womens Sports Act by supporters.

Many legislators who have brought these bills forward refer to a Connecticut case, in which three high school girls are suing over the participation of two transgender athletes in track and field events, saying they have an unfair competitive advantage. The plaintiffs in that case are being represented by the Alliance Defending Freedom, a conservative nonprofit.

But Dylan Waguespack of Louisiana Trans Advocates said the recent crop of bills appearing in state legislatures are evidence that the bills are being pushed by national organizations opposed to LGBT rights.

This legislation is not homegrown, he said. These bills are identical to bills filed in Arizona, and they're very, very similar to bills filed in 15 other states. It kind of actually exposes these bills for what they are, which is imported discriminatory legislation from some fringe national extremist groups.

Early childhood education, affordable housing, infrastructure, the minimum wage, justice reform and equal pay are issues to watch.

Currently, Louisiana policies for transgender peoples participation in sports varies by age. According to Waguespack, schools are left to decide policies for elementary school children. At the high school level, the Louisiana High School Athletic Association (LHSAA) guidelines state that a student-athlete shall compete in the gender of their birth certificate unless they have undergone sex reassignment.

The high school student must then go before a committee who is instructed to allow them to compete on a team matching their gender identity if they have had sex reassignment surgery before puberty. If they have had sex reassignment surgery after puberty, the committee would have to verify whether the person had completed surgical anatomical changes, updated all official government documents and undergone hormone therapy.

Even then, LHSAA states, athletic eligibility in the reassigned gender can begin no sooner than two years after all surgical and anatomical changes have been completed.

Waguespack said these standards are so hard to meet that they amount to a de facto ban on transgender high school students playing on school sports teams that correspond with their gender identity.

I think even folks who aren't living with these issues day to day like I am would know those are not things that are happening to high school students, he said. We wouldn't even recommend that high school students have permanent surgical care. That's something that you do as an adult.

There are no health care providers that would ever provide that kind of care for a minor," he added.

And while, the LHSAA policies are listed as guidelines on their website, Waguespack said the organization does enforce them. A Louisiana high school that allows a transgender person to compete according to their gender identity could potentially have their record disputed and get disqualified for fielding an ineligible player.

LHSAA has made the determination in recent history, like within this past year, that a student who's transgender who meets like all of the things we would expect a high school student to meet is not eligible, he said.

At the college level, the National Collegiate Athletic Association (NCAA) allows transgender women to compete on womens teams if they have completed a year of testosterone suppression treatment, regardless of what their testosterone levels are and if they. Transgender men can compete without medically transitioning.

Gilead Sciences is awarding $163,000 to three New Orleans organizations fighting HIV in 2020.

GLSEN (formerly the Gay, Lesbian & Straight Education Network) lists Louisiana as one of 17 states whose state athletic association has a policy that discriminates against transgender athletes.

Transathlete.com, which monitors policies for across the country, also classified Louisianas K-12 policies as discriminatory but did list Louisiana State University as one of 15 colleges with trans-inclusive intramural athletic policies.

The bills by Amedee and Mizell would restrict transgender athletes participation even further by implementing a policy that mandates student athletes at all levels play on teams that correspond with their sex assigned at birth with no exceptions.

The bill states that if a dispute arises as to the biological sex of a student who participates or desires to participate on a female, girls', or women's school athletic team, a physicians signed statement would determine the students sex assigned at birth.

That determination would be based on the student's internal and external reproductive anatomy, the student's normal endogenously produced levels of testosterone and an analysis of the student's genetic makeup.

It is unclear how such an examination would work in practice. Amedee said physicians who deal with genetics would need to determine a students genetic makeup as outlined in the bill. But she was unsure if a regular primary care physician would be able to provide this service.

We'd have to ask a doctor these things, she said.

Waguespack said not only did he think the examinations and tests outlined in the law would be a massive overreach into the privacy of young people, but that he also was concerned about who would be able to question someones gender and therefore require them to get a physicians statement.

It also sets up this really scary Orwellian system for disputing someone's gender, Waguespack said. It doesn't specify who can dispute someone's gender. It leaves it pretty open to suggest that anyone could.

Eighteen Louisiana equality organizations, including the ACLU of Louisiana, Women With a Vision and Lift Louisiana, recently signed a letter against both bills, calling them a misguided effort to offer the state as a means of enforcing gender norms.

Robb said he is working with the Louisiana LGBT rights organization Forum for Equality to ensure the bill does not pass. Should the bill become law, though, he sees a court challenge as probably inevitable."

These are the sort of laws that in other states where they've passed these things or other forms of discrimination, they've been challenged in court and often successfully."

Originally posted here:
This Louisiana bill would keep trans students from playing on teams matching their gender identity - NOLA.com

Recommendation and review posted by Bethany Smith

The best hospitals in the world must deal with a plethora of challenges facing the health care field today, including tight regulations, rapid advancements in medical science, new health risks and ever-rising costs. And they must do so while also delivering on what must be a medical facility's No. 1 priority: providing top-notch patient care.

What is critical for health care consumers to figure out: Where can you find these industry leaders todaythe ones that meet the economic, political and medical challenges they face with speed and skill, while also providing the very best health care to the people they treat?

To help answer that question, Newsweek partnered with Statista Inc., a global market research and consumer data company, to develop a groundbreaking ranking of the world's best hospitals. The result is our second annual ranking of the best hospitals in the world, the top 10 of which you'll find here.

You find the full ranking, which includes separate lists of top hospitals from 21 countries including the U.S., as well as exceptional specialty hospitals in cardiology, oncology, orthopedics and pediatrics, here.

The largestand originalMayo Clinic has been in Rochester, Minnesota, since 1889. Every year, approximately 1.3 million people from 138 countries come to the Mayo Clinic's 19 hospitals in five states for their specialized team approach. With over 4,800 staff physicians and scientists and over 4,000 full-time research personnel, it is committed to finding answers to the toughest medical cases. Always on the cutting edge, the clinic recently announced several new cancer initiatives. In a counterintuitive move, researchers in Rochester found that by encouraging cancers to mutate, the cancers can be targeted by immunotherapy, and clinical trials for pediatric patients with brain tumors will put this into practice shortly. It also recently announced an agreement to build the first carbon ion therapy treatment center in North America to treat challenging cancers at its Jacksonville, Florida, campus. Patients who seek out the Mayo Clinic appreciate the convenience of its rapid, same-day test results and free concierge services to assist with logistics and travel advice. MayoClinic.org

Cleveland Clinic has always made patient care its centerpiece, and it takes to heart its motto: "Care for the patient as if they are your own family." Historically, Cleveland has also been known for medical breakthroughs and organ transplants, including the first face transplant in the United States. In 2019, it broke its own organ transplant records897, up 3 percent from the year beforeincluding the world's first single-port robotic kidney transplant, which allows for a single small incision and limits the need for postoperative opioids for pain relief. Cleveland's health system encompasses 18 full-service locations systemwide. In 2018, there were 7.9 million outpatient visits, from 185 countries, across all of its campuses. My.ClevelandClinic.org

Over 200 years old and the original and largest teaching hospital of Harvard Medical School, Massachusetts General Hospital is known for its cutting-edge research. Mass General doctors put the insights they gather from that research to good use when diagnosing and treating the nearly 1.6 million patients who walk through its doors annually. With an annual budget of more than $850 million for research and more than 1,200 clinical trials taking place at any time, it is no wonder that Mass General publishes more research articles in prestigious medical journals and receives more federal funding than any other independent hospital in the country. Its researchers' findings range from linking sleep timing and teen obesity to tagging cells using laser particles so as to better understand the growth ofand treattumors. MassGeneral.org

Since 1819, Toronto General Hospital has been a leader in cardiac care, organ transplants and the treatment of complex patient needs. TGH has focused on novel therapies to treat endocrine and autoimmune disorders ever since insulin was developed, and its first clinical use in the treatment of diabetes at the hospital was in 1922. This past year, TGH doctors performed the first robot-assisted brain surgery on a live patient, which they hope will bridge even more frontiers and eventually allow patients in remote communities to get this kind of life-saving care. Its five-year strategic plan focuses on patient well-being and provides regular, transparent performance reviews of health outcomes and patient experience. Uhn.ca

Given that Charit was founded in 1710 when bubonic plague threatened Berlin, it is fitting that, in what is now one of the largest university hospitals in Europe, Charit researchers are taking the lead on identifying and treating infectious diseases such as Zika, SARS and MERS. Charit researchers developed the first diagnostic test to identify the COVID-19 coronavirus, which originated in Wuhan, China. More than half of all German Nobel Prize winners in physiology or medicine can be claimed by Charit as one of its own, and the hospital is internationally renowned for its excellence in teaching and training. In a new partnership announced in July 2019, Charit is integrating the Berlin Institute of Health under its umbrella; according to a statement from the BIH, it "is to becomealongside patient care and the medical facultythe third pillar of Charit." Charite.de

The Johns Hopkins Hospital, founded in 1889 in Baltimore, is not only a leading teaching and research hospital, but it is also central to the history and development of American medical education. William Osler, one of the hospital's founding physicians, invented the idea of medical residency, taking students out of the lecture halls and onto the wards to examine patients. Today Johns Hopkins has 1,162 beds and more than 2,400 full-time attending physicians. Among other firsts, Johns Hopkins was the first hospital in the U.S. to perform male-to-female sex-reassignment surgery. HopkinsMedicine.org

The lineage of this hospital, the first in Zurich, dates back to 1204. It is one of five university hospitals in Switzerland. Currently, it has 43 departments and institutes, ranging from a center on aging and mobility to a department of surgery and transplantation. The hospital has 980 beds, and 1,500 physicians and scientists. It treats over 42,000 inpatients and has over 500,000 outpatient visits every year. In 1977, a physician here successfully restored normal blood flow to constricted coronary arteries using a balloon catheter. Today, the procedure is widely used all over the world. En.Usz.ch

The oldest and largest hospital in this city-state, Singapore General Hospital, a teaching hospital, was founded 1821. Now, it employs more than 10,000 people and sees more than 1 million patients every year. It is home to Southeast Asia's only full multidisciplinary center for cancer and is an acute tertiary referral hospital with over 40 clinical disciplines. In 2010, it was the first hospital in Asia to receive the Magnet designation for nursing excellence from the American Nurses Credentialing Center. Sgh.com.sg

The Sheba Medical Center at Tel Hashomer, near Tel Aviv, serves as Israel's national research and university-affiliated training hospital. It was founded in 1948 as the country's first military hospital. Today, it collaborates with biotech and pharmaceutical companies around the world to develop new drugs and treatments. Serving more than 1.6 million patients a year, its facilities include an acute care hospital, a rehabilitation hospital, a women's hospital, a children's hospital, an eating disorders clinic, a post-traumatic stress disorder clinic forsoldiers and an outpatient clinic. Its research specialties include cardiology, cancer, brain diseases, obstetrics and gynecology, genetics and medical education. https://eng.sheba.co.il/

This hospital, with about 15,000 employees and 1,340 beds, is affiliated with the Karolinska Institute, which was founded in 1810 by King Karl XIII as a school for military surgeons, given the alarm about death rates in army field hospitals. Today it is one of the largest and most prestigious medical schools in the world. The facility incorporates two children's hospitals and is known for its specialties in reproductive medicine, fetal medicine, surgery, urology and neurosurgery. It is a member of 18 referral networks across Europe concentrating on rare diseases. Karolinska.se

Visit http://www.newsweek.com/best-hospitals-2020 for the remaining Top Best Hospitals in the World.

View original post here:
The Top 10 Hospitals In the World - Newsweek

Recommendation and review posted by Bethany Smith

Dog breeders need to take action to improve canine mental health, scientists have said, after research found almost three-quarters of pet dogs have highly problematic anxiety-related behaviour.

While physical problems such as breathing difficulties and other health concerns relating to squashed-nosed breeds have become a hot topic, the study suggests breeders also need to focus on dogs behaviour.

Behavioural problems are the leading cause for the relinquishment or euthanasia of the dogs, said Prof Hannes Lohi, a co-author of the study from the University of Helsinki.

The study, published in the journal Scientific Reports, is based on a survey of owners of more than 13,700 pet dogs in Finland, spanning 264 breeds and ranging from young pups to elderly hounds.

It examined the frequency of seven anxiety-related traits, including noise sensitivity, fear, aggression, separation problems and compulsive behaviour, as well as sub-traits within these categories, such as tail-chasing. For each, dogs were classified as having low, medium or high levels of problems.

It found that 72.5% of dogs had highly problematic behaviour in at least one of the seven categories, and many had multiple problems. Almost a third of dogs showed high sensitivity to noise, with fireworks a particular problem, while 29% of dogs were said to be highly fearful and 14% showed highly problematic aggression.

We observed some differences such as male dogs being more often aggressive and impulsive, while female dogs were more fearful, said Lohi.

There were also differences by age: for example, high noise sensitivity was more common among older dogs, while destructive behaviour when alone classed as a type of separation issue was more common in young dogs.

The team also looked at particular breeds, finding that while dogs of any breed could have any of the anxiety problems, particular traits were more common in certain types of dog.

As a result, selective breeding focusing on behaviour may reduce the prevalence of canine anxieties, the authors said.

Miniature schnauzers, for example, had high levels of aggression both towards strangers and family members, and a fear of strangers, while nearly 10% of Staffordshire bull terriers chased their tail.

Perhaps surprisingly, the team found that mixed breeds were more likely to show many of the various traits than purebred dogs although the researchers say that may be because many of the former were probably rescue animals that potentially had had a difficult start in life and a lack of socialisation.

The study has limitations: it is not clear if the trends would hold in other countries, and the team only looked at the frequency of behaviours and not their severity. It may also be that owners of dogs with behaviour problems may have been more likely to complete the questionnaire, although the researchers say their study was advertised to all owners and the findings chime with other research.

Dr Rowena Packer, an expert in animal behaviour and welfare from the Royal Veterinary College, said a dogs genetics and their environment each contributed to the way they act.

The way that both breeders and owners interact with dogs is hugely important in raising mentally healthy dogs, she said. This includes appropriate socialisation to people and other animals and habituation to day-to-day experiences as puppies, and positive, force-free training throughout life.

Packer noted that when it comes to heritable traits, too often the emphasis is on looks over behaviour. She said that because genetics and early environment set up dogs for the rest of their lives, breeders must do more to produce behaviourally healthy dogs.

Some of the behavioural problems highlighted in this study can lead to a lifetime of misery for affected dogs and an emotional and financial burden on their owners, she said. Tackling these problems through selection of behaviourally sound breeding stock, along with educating owners on appropriate interactions, environment and training for dogs, should be a high priority for all dog lovers.

Visit link:
Dog breeders urged to act over high levels of anxiety in pets - The Guardian

Recommendation and review posted by Bethany Smith

]]> The system is being deployed on Canadian LAVs. Image: Elbit Systems.

Elbit Systems has been selected to supply its Satellite-on-the-Move (SOTM) communications system to the Canadian Armed Forces Land Command Support System Life Extension (LCSS LE) programme under a deal with Rheinmetall Canada.

Under the contract Elbit will provide the Canadian Armed Forces with the triple-band ELSAT 2100 SATCOM on-the-move system, which provides personnel with broadband communications using both military and commercial satellites.

Elbit Systems C4I & Cyber Division executive vice-president and general manager Haim Delmar said: We are proud of our ongoing work with the Canadian Armed Forces, providing them with networked combat solutions.

We will continue to focus on developing and delivering superior networked warfare technologies to Canada and additional Five Eyes countries.

According to Elbit, the system will allow the Canadian Armed Forces to maintain voice and data communications at long ranges using the US Department of Defence (DoD)s Wideband Global SATCOM (WGS) network.

A key focus of the LCSS LE programme is to improve the network capabilities of Canadas land forces. On top of satellite communications capability, Canada is also looking to improve smaller local network capabilities.

Elbit has in the past provided the ELSAT 2100 to Canada under an earlier contract signed in 2014. In the past year, the company has provided a number of systems to the Royal Canadian Navy including an off-board electronic countermeasure payload for the Hammerhead unmanned surface vessel, also as part of a contract with Rheinmetall Canada.

Originally posted here:
Elbit to supply on-the-move communications system to Canada - Army Technology

Recommendation and review posted by Bethany Smith

The Southern Exposure 2020 trade show was held in Tampa this past weekend. The day before the trade show several educational sessions were held. The first of these sessions was entitled The Plight of Plastics, and consisted of a panel of five people: Janis McIntosh of Naturipe Farms, Natalie Shuman of Apeel Science, Brad Dennis of CKF Inc., Kathy Lawrence of Proseal and Elizabeth Yerecic of Yerecic Label. The panel was led by Anabella de Freeman of Walmart Stores.

De Freeman opened the session by explaining the initiatives taken by Walmart for reducing the use of plastics. She said: Walmart has made the commitment to have 100% recyclable packaging for all our private label products by 2025. Our call to action consists of three parts: use less plastics, make it recyclable, and label it.

After de Freemans introduction, each of the panelists received some time to explain how their company views the plight of plastics and what they are doing to help improve the situation.

Commitment to reduction of plasticJanis McIntosh of Naturipe Farms started by saying: I like to call the situation not the plight of plastics, but rather the opportunity of plastics. Recently, the CPMA released their Plastics Technical Report which showed that plastics is needed in berry packaging. So we need to take this opportunity to innovate our plastic use. The issue doesnt require us to eliminate all plastic, but it does require us to eliminate all plastic waste and make it recyclable. We at Naturipe commit to reducing plastic and increasing recyclability.

She added: Change is good, but its better together. To have the most impact, everyone needs to work together and competitors need to ally themselves with each other. This was an important message reiterated by each of the panelists. An example of this cooperation is the commitment of North American berry growers to use 100% recycle-ready packaging by 2025.

Shelf-life and product protectionPanels like this help us realize how we can evolve and innovate as an industry. At Apeel Science we work together with nature to reduce waste and ensure an abundant future for our planet, said Natalie Shuman of Apeel Sciences.

Plastic packaging is often used to elongate a products shelf life. Apeel Sciences works to extend products shelf-lives through a natural, plant-derived product which helps fight food waste and plastic use. While food waste is a sustainability and environmental issue, it is also an economic issue. Shuman explained that US food businesses lose millions of dollars on food waste.

She says: Plastic packaging has multiple purposes: grouping, protection, marketing and shelf-life extension. At Apeel, we tackle this last purpose to help reduce the need for plastic packaging. Our technology uses the molecular building blocks of plants to help create the optimal microclimate within foods. This helps extend the products shelf-life and gives the industry more time at each step of the supply chain.

Alternative packaging optionsBrad Dennis represented CKF Inc., a Canadian packaging company that offers alternatives to plastic packaging. We work with packaging made out of molded pulp. One of our product lines, EarthCycle, uses an optimal blend of virgin hardwood and recycled corrugate. Each of our products are made in North America, and all the materials are sourced from North America as well.

Besides being made of recycled, non-plastic materials, the company goes a step further: the packaging is certified home-compostable. Other benefits of this type of packaging is an up to 20% shelf-life extension, a reduction of over 90% in single use plastics, as well as a 5% sales increase for retailers, Dennis concluded.

Panelist Kathy Lawrence represented ProSeal, a company originating in the UK, whose range of top seal machinery includes 20 different machines specializing in sealing processes. She said: One of the ways we can reduce plastic is by replacing a clamshell lid by a top seal. Not only does this reduce the amount of plastic in the packaging, it also helps reduce warehouse space. We also work with shelf-life extension solutions. Specific top seal materials help control respiration rates and this can help fight food waste.

LabelingElizabeth Yerecic of Yerecic Label helped explain to the audience the issues they may run into with their product labels. While labels themselves do not contribute to the high source of single-serve plastics, they do contribute to the lack of recyclability of single-serve plastics. In order for labels to be sustainable, they need to have aspects such as degradable additives and friendly inks, said Yerecic.

Another issue with labels is the adhesive. The adhesive needs to be able to wash away during the caustic bath at the recycling facility. This is something that is largely the responsibility of the brand owners to ensure that the labels they use in their packaging has all the right components, Yerecic explains. If a label doesnt meet all the necessary requirements, then it is possible that the entire package will not be recycled.

In order to make headway on the plight of plastics, people in each step of the supply chain need to take responsibility. The general conclusion of the panel was that plastic is a necessary material in the industry, for product protection and other purposes, but the way in which it is used needs some major improvement. While many changes have already been made, the best way to move forward is by allying with competitors. While they might be your competitors within the industry, the goal of creating a better and more sustainable future is a shared goal that can only be reached through combined efforts.

Original post:
Change is good, but it's better together - FreshPlaza.com

Recommendation and review posted by Bethany Smith

By Warren Slaten, M.D. | March 05, 2020

Menopause is not a disease. It is a normal phase of life that marks the end of the menstrual cycle. However, during early adulthood, women are protected by several hormones including estrogen and progesterone. These hormones help women maintain good heart health and help women maintain their bones. They also help women think clearly. When these hormones are lost at menopause, women become more vulnerable to heart diseases, osteoporosis with hip fractures and Alzheimers disease. These happen to be the three leading causes of death in older women.

Since the famous Womens Health Initiative (WHI) study, which was initially published in 2002, the use of hormones declined dramatically. Thats because the study authors and the media exaggerated the studys negative findings and underemphasized the studys many positive findings. As a result, a mass panic developed about hormone replacement such that most physicians stopped prescribing it and most women wanted nothing to do with it.

Unfortunately, when they stop using hormones, which is the most effective way to prevent the three greatest causes of womens death, women are more vulnerable to these three diseases. There have been several medical journals in the last two years that have published articles highlighting the decreased life expectancy for women as a result of not protecting themselves with hormone replacement.

The most common response I hear when I speak to women about hormone replacement is that they are afraid of breast cancer. However, this is pure myth. Estrogen does not cause breast cancer. In fact, the compendium of studies reveal that estradiol actually mildly reduces the incidence of breast cancer. The one hormone that was associated with breast cancer was Provera, which is a synthetic version of progesterone. The natural or bioidentical version actually protects against cancer as progesterone is anti-proliferative. This means that progesterone reduces the progression of cancers. The ironic thing is that as the subjects continued to be followed over the ensuing five years, even Proveras cancer association weakened, but this did not make for good headlines so even most doctors are not aware of this result. The bottom line is that estrogen does not cause cancer and, if anything, provides some protection against breast cancer. Bioidentical progesterone further protects against cancer.

The other error that many doctors make is the misconception that hormone replacement causes strokes and heart attacks. This is because in the WHI study, some of the older women started on hormone replacement had an increased risk for cardiac events during the first year they took hormones. As noted above, estrogen protects against heart disease and younger women had cardiac benefit in the WHI study. The presumed basis for these events is that estrogen causes clots to be dislodged. The older women in the study were more likely to have clots and once the clot is dislodged, strokes and heart attacks can result. Interestingly, these events tend to occur in the first year. After that, even older women received cardiac benefit from estrogen.

Another source of the cardiac error is that in the WHI study, Premarin was used. Premarin is a truncated word for pregnant mares urine. Animal rights issues aside, the biggest concern about Premarin is that it is a stronger estrogen than estradiol, which is the bioidentical version of what humans naturally produce. As a stronger estrogen, Premarin has a tendency to dislodge clots but no study has ever shown that estradiol has such a tendency. Thus, bioidentical estradiol is not associated with heart attacks or strokes. To the contrary, the relative risk of heart disease for women who take estradiol is 0.4 compared to women who do not take estradiol. That means that if a woman does not take estradiol, she is 2.5 times more likely to get heart disease.

The most costly error is that medical societies and organizations have generally recommended hormone replacement for women only when they are having menopausal symptoms such as hot flashes and to take them for the shortest possible time at the lowest dose that reduces symptoms. However, we have learned that women who have hot flashes are at higher risk of the diseases associated with menopause, including heart disease, osteoporosis and Alzheimers. One study found that women with hot flashes had increased white matter loss on brain MRIs. Even insulin resistance, which is associated with diabetes mellitus, is increased in women with hot flashes. By taking hormone replacement, women significantly reduce the risk of these diseases. The misconception that women should minimize hormone use has deprived them of a key tool to reduce the risk of such deadly diseases.

Women have been led to believe that hormone replacement is very dangerous. Many women do not even consider hormone replacement because of this; I often see a visceral reaction against hormones that is based on misleading information. I am optimistic to see the medical community starting to realize the harm caused by discouraging hormone use.

Menopause is a challenging time for many women. It is often accompanied by weight gain of 10-20 pounds, increased fatigue, insomnia, depression, decreased libido and even increased joint and muscle pain. I hope that women are encouraged that with bioidentical hormones, women can reverse all these symptoms with weight loss, improved energy, improved mood, improved sleep and improved libido. At the same time, women can reduce the risk of the three leading causes of death for older women, including heart disease, osteoporosis with deadly hip fractures and Alzheimers disease. So by starting bioidentical hormone replacement, you reduce your risk of disease and improve your quality of life.

Dr. Slaten is a wellness physician specializing in regenerative pain treatments and lifestyle counseling. He is certified in advanced bioidentical hormone replacement.

Visit link:
Misinformation That May Be Costing Women Their Lives - Jewish Link of New Jersey

Recommendation and review posted by Bethany Smith

The Global Testosterone Gel Market report provides a holistic evaluation of the market for the forecast period (20192026). The report comprises of various segments as well an analysis of the trends and factors that are playing a substantial role in the market. These factors; the market dynamics, involves the drivers, restraints, opportunities and challenges through which the impact of these factors in the market are outlined. The drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market. The Global Testosterone Gel Market study provides an outlook on the development of market in terms of revenue throughout the prognosis period.

Request Exclusive Free Sample PDF Of This Report At https://www.upmarketresearch.com/home/requested_sample/56462

Global Testosterone Gel Market: Scope of the Report This report provides an all-inclusive environment of the analysis for the Global Testosterone Gel Market . The market estimates provided in the report are the result of in-depth secondary research, primary interviews and in-house expert reviews. These market estimates have been considered by studying the impact of various social, political and economic factors along with the current market dynamics affecting the Global Testosterone Gel Market growth.

Along with the market overview, which comprises of the market dynamics the chapter includes a Porters Five Forces analysis which explains the five forces: namely buyers bargaining power, suppliers bargaining power, threat of new entrants, threat of substitutes, and degree of competition in the Global Testosterone Gel Market. It explains the various participants, such as system integrators, intermediaries and end-users within the ecosystem of the market. The report also focuses on the competitive landscape of the Global Testosterone Gel Market.

Global Testosterone Gel Market: Competitive Landscape The market analysis entails a section solely dedicated for major players in the Global Testosterone Gel Market wherein our analysts provide an insight to the financial statements of all the major players along with its key developments product benchmarking and SWOT analysis. The company profile section also includes a business overview and financial information. The companies that are provided in this section can be customized according to the clients requirements.

For More Information on this report, Request Inquiry At https://www.upmarketresearch.com/home/enquiry_before_buying/56462

Testosterone Gel Market can be segmented into Product Types as 0.010.0162

Testosterone Gel Market can be segmented into Applications as Primary hypogonadismHypogonadotropic hypogonadismLate-onset hypogonadism

Testosterone Gel Market: Regional analysis includes: Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) North America (United States, Mexico, and Canada.) South America (Brazil etc.) The Middle East and Africa (GCC Countries and Egypt.)

Major Players included in this report are as follows AbbVieTevaPerrigoEndo PharmaceuticalsAcerus PharmaceuticalsLupinDr. Reddys LaboratoriesUpsher-Smith Laboratories

Global Testosterone Gel Market: Research Methodology The research methodology is a combination of primary research secondary research and expert panel reviews. Secondary research includes sources such as press releases company annual reports and research papers related to the industry. Other sources include industry magazines, trade journals, government websites and associations were can also be reviewed for gathering precise data on opportunities for business expansions in Global Testosterone Gel Market.

Research Methodology of UpMarketResearch Primary research involves telephonic interviews various industry experts on acceptance of appointment for conducting telephonic interviews sending questionnaire through emails (e-mail interactions) and in some cases face-to-face interactions for a more detailed and unbiased review on the Global Testosterone Gel Market, across various geographies. Primary interviews are usually carried out on an ongoing basis with industry experts in order to get recent understandings of the market and authenticate the existing analysis of the data. Primary interviews offer information on important factors such as market trends market size, competitive landscape growth trends, outlook etc. These factors help to authenticate as well as reinforce the secondary research findings and also help to develop the analysis teams understanding of the market.

To purchase this report Full Or Customized, Please Visit https://www.upmarketresearch.com/buy/testosterone-gel-market

Reasons to Purchase this Report: Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors Provision of market value (USD Billion) data for each segment and sub-segment Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players The current as well as future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions Includes an in-depth analysis of the market of various perspectives through Porters five forces analysis Provides insight into the market through Value Chain Market dynamics scenario, along with growth opportunities of the market in the years to come

For Best Discount on purchasing this report, Visit https://www.upmarketresearch.com/home/request_for_discount/56462

About UpMarketResearch:Up Market Research (https://www.upmarketresearch.com) is a leading distributor of market research report with more than 800+ global clients. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Contact Info UpMarketResearchName Alex MathewsEmail [emailprotected]Organization UpMarketResearchAddress 500 East E Street, Ontario, CA 91764, United States.

Read the original here:
Global Testosterone Gel Market Insight Growth Analysis on Volume, Revenue and Forecast to 2019-2026 - 3rd Watch News

Recommendation and review posted by Bethany Smith

Analystview market insights has added a new report titled,Hormone Replacement Therapy (HRT) Market research report provided by Analystview market insights is a complete study of the Global Hormone Replacement Therapy (HRT) Market in its vast database of research reports.The report presents a comprehensive scenario of the market so as to calculate the market size, based on the way of study, synthesis, and summation of data from multiple sources. The global , which covers all the necessary information required by new market entrants as well as the existing players to gain a deeper insight into the market.

The report offers a complete company profiling of leading players competing in the global Hormone Replacement Therapy (HRT) market with high focus on share, gross margin, net profit, sales, product portfolio, new applications, recent developments, and several other factors. It also throws light on the vendor landscape to help players become aware of future competitive changes in the global Hormone Replacement Therapy (HRT) market.

Get Free Sample of This Report @ https://www.analystviewmarketinsights.com/request_sample/AV181

The main company in this survey is: Amgen, Inc., Novo Nordisk, Eli Lily, Abbott, and Genentech

By the Replacement therapy, the market is primarily split into : Estrogen, Human Growth Hormone, Testosterone, Thyroid,

By the Route of Administration, the market is primarily split into : Parenteral, Oral, Transdermal, Other,

By the Disease, the market is primarily split into : Male Hypogonadism, Menopause, Hypothyroidism, Growth Hormone Deficiency, Others,

Regional Market Analysis

This is one of the most valuable portions of the research study that helps readers to gain a quick understanding of the advancement of the global Hormone Replacement Therapy (HRT) markets in different parts of the world. The regional analysis provided in the report can be a powerful tool that market players can use to increase their presence in the global Hormone Replacement Therapy (HRT) markets. Each geographical market studied in the report is analyzed on the basis of crucial factors such as gross margin, market share, production, price, consumption, and CAGR.

Buy Full Report @ https://www.analystviewmarketinsights.com/product/hormone-replacement-therapy-hrt-market

The research report is broken down into chapters, which are introduced by the executive summary. Its the introductory part of the chapter, which includes details about global market figures, both historical and estimates. The executive summary also provides a brief about the segments and the reasons for the progress or decline during the forecast period. The insightful research report on the global Hormone Replacement Therapy (HRT) market market includes Porters five forces analysis and SWOT analysis to understand the factors impacting consumer and supplier behavior.

What does the report offer?

An in-depth study of the Global Hormone Replacement Therapy (HRT) Market, including a complete evaluation of the parent market. A thorough analysis of the market providing a complete understanding of the market size and its commercial landscape. Hormone Replacement Therapy (HRT) market evaluation by upstream and downstream raw materials, present market dynamics, and subsequent consumer analysis. Analysis providing the driving and restraining factors of the Global Hormone Replacement Therapy (HRT) Market and its impact on the global industry. A thorough understanding of Hormone Replacement Therapy (HRT) industry plans that are now increasingly being adopted by leading private businesses. Value chain analysis of the market, providing a clear understanding of the key intermediaries involved, and their individual roles at every phase of the value chain. Porters five forces analysis of the market, elaborating the efficiency of purchasers and sellers to develop efficient growth strategies. Competitive landscape analysis, highlighting the leading competitors in the market so as to understand the strategies adopted by them.

Table of Contents

Overview: Includes product scope, highlights of segment analysis, and Hormone Replacement Therapy (HRT) market size forecast.Competition Includes production, revenue, and average price shares by manufacturers and sheds light on competitive situations and trends.Regional Production: Focuses on production, revenue, price, and gross margin of regional Hormone Replacement Therapy (HRT) markets.Consumption: Focuses on regional consumption in different parts of the world.Research Findings and Conclusion: Tells what the analysts make of this research study and the global Hormone Replacement Therapy (HRT) and includes valuable suggestions for achieving market success.

Get access to full summary @ https://www.analystviewmarketinsights.com/report-highlight-hormone-replacement-therapy-hrt-market

Please contact our professional [emailprotected], we will ensure you obtain the report which works for your needs.

Go here to read the rest:
Hormone Replacement Therapy (HRT) Market to Witness Promising Growth Opportunities During 20202025 with Top Leading Players Amgen, Inc., Novo Nordisk,...

Recommendation and review posted by Bethany Smith

From humans to black-tailed prairie dogs, female mammals often outlive males but for birds, the reverse is true.

Now researchers say they have cracked the mystery, revealing that having two copies of the same sex chromosome is associated with having a longer lifespan, suggesting the second copy offers a protective effect.

These findings are a crucial step in uncovering the underlying mechanisms affecting longevity, which could point to pathways for extending life, the authors write. We can only hope that more answers are found in our lifetime.

The idea that a second copy of the same sex chromosome is protective has been around for a while, supported by the observation that in mammals where females have two of the same sex chromosomes males tend to have shorter lifespans. In birds, males live longer on average and have two Z chromosomes, while females have one Z and one W chromosome.

Scientists say they have found the trend is widespread. Writing in the journal Biology Letters, the team report that they gathered data on sex chromosomes and lifespan across 229 animal species, from insects to fish and mammals. Hermaphroditic species and those whose sex is influenced by environmental conditions such as green turtles were not included.

The results reveal that individuals with two of the same sex chromosomes live 17.6% longer, on average, than those with either two different sex chromosomes or just one sex chromosome.

The team say the findings back a theory known as the unguarded X hypothesis. In human cells, sex chromosome combinations are generally either XY (male) or XX (female). In females only one X chromosome is activated at random in each cell.

As a result, a harmful mutation in one of the females X chromosomes will not affect all cells, and hence its impact can be masked. By contrast, as males only have one X chromosome, any harmful mutations it contains are far more likely to be exposed.

The team found that in species where males have two of the same sex chromosomes, these males live on average 7.1% longer than females. However, in species where the sex chromosome pattern is the other way around, such as humans, females live 20.9% longer on average than males.

The researchers say the extent of the longevity gap may reflect other factors at play, including that males tend to take more risks when it comes to securing a sexual partner, including fighting. These pressures to travel far to find a mate, establish a territory and compete with other members of your sex are not seen often in females, said Zoe Xirocostas, a co-author of the research from the University of New South Wales.

But there are also other possibilities as to why the longevity gaps differ in size, including that oestrogen appears to protect the ends of chromosomes from being damaged a process linked to ageing.

Our study suggests that the unguarded X is an underlying genetic factor that can influence lifespan, but many external factors can influence longevity in different ways such as predation, risky behaviours, establishing territories and access to quality nutrition, said Xirocostas.

Prof Steven Austad, an expert on ageing at the University of Alabama at Birmingham, who was not involved in the study, said the theory that having two of the same sex chromosomes is beneficial for longevity was appealing.

I would think that it plays some role in understanding sex differences in longevity but it certainly isnt the only factor, he said, noting that both risk-taking behaviour and parental roles also appeared to be important. For instance, owl monkey males live longer than females and the males play a big role in infant care in that species, he said, noting such males have two different sex chromosomes.

Austad said the upshot was that longevity is not only about sex chromosomes. There is a general trend, but with numerous exceptions, he said.

The rest is here:
Mystery of lifespan gap between sexes may be solved, say researchers - The Guardian

Recommendation and review posted by Bethany Smith

Have you noticed there's more hair on your brush after brushing it, that your parting looks wider, or that your ponytail feels feels less substantial than it used to? Once you notice hair thinning, its hard not to think about it every time you look in a mirror.

Some hair loss is normal we shed approximately 100 hairs a day but what to do when it's a significant amount? Hair thinning and loss in women can have many causes, and are often a combination of factors. It's especially common as we hit mid-life. Here we explore some of the most common causes and share expert tips on what to do when you start to lose your hair.

Dozens of medical issues from autoimmune conditions and hormonal imbalances to scalp infections and genetics can cause hair loss and thinning . A doctor or trichologist can carry out a full medical history, blood tests and a scalp biopsy to help you work out whats causing it.

Androgenetic alopecia or female pattern hair loss is by far the most common a quarter of women have it and youll notice it as thinning especially at the crown and the temples. It happens when a sensitivity to male hormones (androgens) causes follicles to shrink over time. "The hair becomes thinner until eventually the follicle closes over altogether," explained Dr Martin Wade a dermatologist at The London Skin and Hair Clinic.

Sol de Zuasnabar BrebbiaGetty Images

If it starts in your teens, its considered to be genetic. If it starts in midlife, from 35 to 55, it can be a combination of factors including hormonal changes and lifestyle, which a doctor can help you to unpick.

Post-menopausally, its also called senescent alopecia, which basically means were getting older and everything slows down.

But all is not lost... "In genetic cases, some of the smaller follicles can recover with anti-androgenetic drugs such as finasteride or spironolactone," says Dr Wade. For mid-lifers, topical minoxidil such as Regaine For Women, can help the hair grow thicker and faster.

Boots

Regaine For Women Regular Strength

25.95

When the hair falls out in patches, its often down to alopecia areata, an autoimmune condition that affects 2% of women. "Its still largely a mystery as to why it strikes, although stress is a known trigger," said Dr Wade. "We can treat it with steroids and in most cases, the hair grows back."

We might think our hair is essential, but in evolutionary terms its the first thing that the body deprioritises when were in crisis. Crash diets, illness, divorce or the loss of a loved one can lead to diffuse (ie all-over) hair shedding called telogen effluvium. Dr Wade explained: "Stress shocks the hair prematurely out of the growth phase and into the resting phase." You might notice less hair overall or wonder why your hair just wont grow as long as it did. "If the stress is acute, typically the shedding lasts for three months and then turns itself off," Dr Wade said.

If stress is ongoing, then its another story. "There is absolute association between chronic telogen effluvium and stress," confirmed Dr Justine Hextall of the Tarrant Street Clinic in Arundel. "Addressing the causes of your stress is imperative. Often when were stressed we also dont eat well, so looking at diet and supplements as well as whether you might be pulling at your hair due to stress can all help."

Even the type of exercise you do can add to your stress load. Consider choosing yoga over HIIT.

Ariel SkelleyGetty Images

In the meantime, there are a range of cover-up solutions. Try hair fibres such as Nanogen Hair Thickening Fibres or Toppik Hair Building Fibres, or hair makeup such as the Bumble and Bumble Color Stick.

Shop cover up solutions

Hair Thickening Fibres Medium Brown

18.95

Hair Building Fibres Medium Brown

Bb.Color Stick

23.00

Viviscal Hair Thickening Fibres for Women

15.99

As we move towards menopause and oestrogen levels drop, theres less of a buffer against the effect of male hormones on our follicles. As we know from female pattern baldness, a sensitivity to androgens causes the follicles to miniaturise and die over time.

There are products to tackle this topically: Plantur 39 Shampoo and Tonic have a phyto-caffeine complex to fight the effects of testosterone on the hair root, while Tricho 7 Step 2 scalp drops by Philip Kingsley contains zinc sulphate, azelaic acid and vitamin B6 to reduce the conversion of testosterone.

Phtyo Caffeine Tonic

10.49

Phyto-Caffeine Shampoo

9.75

Tricho 7 volumizing hair & scalp treatment

45.00

Pro-V Expert Collection AgeDefy Advanced Thickening Treatment, 24

Panteneamazon.com

Its important to support the adrenal glands too, says nutritional therapist Eve Kalinik, not only because they are overworked at this often stressful life stage, but because they step in to produce sex hormones as the ovaries retire. "This causes a knock-on effect on hormonal balance, which can manifest as hair loss or thinning," she explained.

Supporting the adrenal glands with anti-inflammatory healthy fats, B vitamins and anti-oxidant vitamins (A,C,E) is vital to make us more stress resilient.

There are some nutrition basics when it comes to hair health says Eve. "Hair is mostly protein, so make sure you get a serving with every meal, using your palm as a measure of the amount you need, which depends on your own body size," she explained. Omega 3 fats, found in oily fish, organic eggs, flax, chia and walnuts, nourish the follicles.

SCIENCE PHOTO LIBRARYGetty Images

Vegans should soak pulses, legumes and grains before cooking to gain the maximum protein and iron from them.

Iron too (in red meat, full fat dairy, eggs and lentils) is vital to nourish healthy hair. Runners may need extra iron due to "foot strike haemolysis" where red blood cells are damaged by the impact of running. You may also be low on iron if you have heavy periods.

What you eat is only the first piece of the nutrition/hair puzzle. "You are also what you absorb," Eve explained. "A poorly functioning digestive system can be a sign that were not getting hair nutrition from our food. Light coloured floating stools can suggest that your gut is not absorbing fats, for example." Eve often recommends a stool test for a fuller gut health picture and liquid probiotics such as Symprove to support the gut.

If you have hair thinning or shedding and youre also tired with dry skin and gaining weight, Eve recommends a blood test to check your thyroid.

Switching up your haircare routine can make a big difference to hair health. Most experts agree that heated styling tools are a no-no for fragile hair, so cut down your use or cut them out altogether. Avoid products with silicones, too (look for anything ending in "cone" on the label) recommended hairdresser Paul Windle. "Silicones are sealants," he explained, "They are what gives you that fake 'plastic' shine. You think your hair is healthy, however, the silicone merely masks the problem." They can also weigh down fine hair.

Chakrapong Worathat / EyeEmGetty Images

Keeping the scalp clear of build-up can help those ever more delicate menopausal hairs push through. Try Briogeo Scalp Revival, which is silicone-free with detoxing charcoal to clear the scalp from dead skin, pollution and product build-up, or Kerastase Soothing Scrub Apaisant , which is designed for sensitive scalps with an uplifting citrussy scent. Beware of scalp oils however, Dr Wade cautioned that they can have a toxic effect on the follicle.

Charcoal + Coconut Oil Micro-Exfoliating Shampoo, 39.99

Briogeobriogeohair.com

Soothing Scrub

34.40

Cleansing Purifying Scrub with Sea Salt

17.00

Clarifying Scalp Exfoliant

20.00

Like this article? Sign up to our newsletter to get more articles like this delivered straight to your inbox.

SIGN UP

See the original post here:
Everything you need to know about losing your hair as you get older - goodhousekeeping.com

Recommendation and review posted by Bethany Smith

captionSometimes cats engage in puzzling behavior thats hard to understand.sourceShutterstock

Whether you own a cat or not, there are probably a few things youve always wondered about them.

And so, Insider spoke with veterinarians to get answers to a few common cat questions that you might have.

Contrary to popular belief, cats cannot sniff out people who are allergic to them, Rover veterinarian Gary Richter told Insider.

He explained that if cats are paying extra attention to someone with allergies, its likely because they are responding to that persons body language.

People with allergies tend to ignore or avoid the cat in the room, which reduces the felines fear of an unfamiliar person. Cats are most likely to be drawn to someone who gives them their space and allows them to approach the human first, said Richter.

Some felines seem to lose control when they are around catnip. Fortunately, as Richter told Insider, the plant isnt harmful to or addictive for cats.

Some cats are drawn to catnip because it takes over their olfactory senses. There is no harm in letting your cat enjoy the scent should they be attracted to it catnip can be used for training or playtime, said Richter.

But keep in mind your cat might begin to feel nauseous or become irritated if you give them too much of it.

Veterinarian Megan Teiber said that its possible to train a cat to use a toilet but the drawbacks may outweigh the benefits of being able to flush your cats waste away.

A change in urine production is often the first sign of a serious medical condition, and if the cat is using the toilet as opposed to the litter box, this is more likely to be missed, said Teiber.

Its also worth noting that if a family member accidentally leaves the toilet lid down, closes the bathroom door, or is occupying the bathroom, the cat may have accidents around the house.

Some folklore holds that cats can tell if someone is pregnant and are drawn to people who are expecting but no, cats are not furry pregnancy tests.

Richter explained that cats just have an incredible sense of smell and are great at reading body language.

During pregnancy, women experience profound changes in their hormone levels which can affect their personal scent, so cats can understand that something is changing based on the new smell, said Richter.

Plus, a persons body temperature often rises in the first trimester of pregnancy. So if you notice a cat snuggling up to someone who is pregnant, they might just be enjoying the extra body heat.

Although male cats have a reputation for being more companionable than female cats, Teiber said there arent significant personality differences between the two.

A lot of people seem to think that male cats are generally more affectionate than female cats. I think there is simply a lot of individual variation and that there is no clear difference between male and female cats, said Teiber.

Some cats do fine when eating only dry food. However, wet cat foods are generally higher in protein and are always higher in moisture than dry foods, which more closely matches feline nutritional needs, said Jennifer Coates, veterinarian and advisor at Pet Life Today.

And as Jaimee Alsing, an animal nutritionist with PurringPal, previously told Insider, cats can actually avoid chronic dehydration by having wet food in their diet.

Chronic dehydration too often leads to tooth decay, bladder stones, and urinary tract infections. Many health issues can be prevented simply by adding a daily meal of wet food to your cats diet, said Alsing.

But Coates said if you still insist on feeding your cat only dry food, give it to them in several small, measured meals throughout the day rather than leaving a bowl of it out at all times.

Teiber said that sometimes female cats appear more affectionate to their owners after a spay, but spaying doesnt actually alter a cats personality.

Prior to being spayed, female cats frequently cycle in and out of heat, so their energy is often focused on mating. Once they are spayed, they may be able to relax and focus more attention on their human companions, said Teiber.

According to VCA Animal Hospitals, after they are neutered, male cats may behave less aggressively and spray less, though overall cat personality is still mainly a product of genetics and upbringing.

Carrying around extra fat can put felines in danger of developing chronic health conditions. Fortunately, it can be easy to tell if your cat is overweight.

When looking down on them from above, overweight cats lack a discernible waist. From the side, an overweight cats belly is closer to the ground than [it is to] the chest, said Coates.

Another sign that your cat is too plump is if you cannot feel their last few ribs by lightly running your hands over their sides, Coates added.

Read More:

See the article here:
Veterinarians answer 8 questions about cats that youve always wanted to ask - Business Insider

Recommendation and review posted by Bethany Smith

2020 is already promising to be a fantastic year for space exploration. The next generation of Artemis explorers can begin applying for the program that will be journeying to the Moon, Mars and beyond; the James Webb Space Telescope is ready to test key deployments made in space, and even the Orion spacecraft that will blast off to the Moon during Artemis missions has successfully passed its final tests. Furthermore, NASA and commercial space companies prepare for the colonization of orbit, rockets are taking payloads to the International Space Station (ISS) very often and 3D bioprinting is becoming an attractive and useful method to carry out experiments. The next one up is SpaceX mission CRS-20. Scheduled to launch at 11:50 PM Eastern Time (EST) on March 6 from Floridas Cape Canaveral Air Force Station, the unpiloted cargo spacecraft is expected to arrive at the orbiting laboratory two days later with three Techshot-managed research campaigns.

The Indiana-based commercial research company is sending equipment and samples supporting plant, heart and cartilage research for NASA, Emory University and the Uniformed Services University of the Health Sciences (USU) to the ISS. According to the company, astronauts onboard the station will use Techshots 3D BioFabrication Facility (BFF) mounted inside the ISS U.S. National Laboratory (ISS National Lab) since last summer to manufacture human knee menisci for the 4-Dimensional Bioprinting, Biofabrication, and Biomanufacturing, or 4D Bio3program. Based at USU, 4D Bio3 is a collaboration between the USU and The Geneva Foundation, a non-profit organization that advances military medical research.

Funded by the U.S. Defense Health Program and managed by the Geneva Foundation, 4D Bio3promotes the development and application of advanced bioprinting, biofabrication, and biomanufacturing technologies for research pursuant to U.S. Department of Defense priorities and ultimately for translation to clinical medical defense care and training solutions.

This is our most diverse manifest to date, said Techshot President and CEO, John Vellinger. Throughout March well be conducting three major investigations in space for three customers using three very different Techshot-built research devices. Its going to be a busy month, but were excited to see the results.

Techshot owns BFF and the company built it at a cost of approximately seven million dollars. The starting point was an nScrypt printer, which now is highly modified by Techshot for use inside the ISS. In that relationship, Techshot handles all the space bioprinting, while nScrypt handles all the Earth-based bioprinting.

This first experiment for 4D Bio3 next month will be used as a test of the materials and the processes required to print a meniscus in space. Techshot engineers will upload a design file to BFF from the companys Payload Operations Control Center in Greenville, Indiana, and evaluate its success via real-time video from inside the unit. A second meniscus print will take place in BFF early next year and the item will then be returned to Earth for extensive testing and comparison to the nScrypt Earth-printed items. Last year nScrypt printed the same thing at a U.S. military base in Africa with their own printer.

Vincent B.Ho, Director of 4D Bio3 and professor and chair of radiology at USU said that meniscal injuries are one of the most commonly treated orthopedic injuries, and have a much higher incidence in military service membersreported to be almost 10 times that of the civilian population. We successfully biofabricated 3D human medial and lateral menisci in a pilot study performed in Africa last summer and anticipate learning valuable lessons on the challenges and benefits of biofabrication in microgravity by performing a similar experiment on the space station.

Besides BFF, there are four other Techshot owned and operated research machines inside the ISS today. Only the BFF is a bioprinter. The others are an X-ray machine for mice, two identical units called the Techshot Multi-use Variable-gravity Platform (MVP), and one called the ADvanced Space Experiment Processor (ADSEP), which is where cells printed in the BFF go to become conditioned and cultured into the tissue. The company has agreements with NASA and the ISS National Lab that permit Techshot to operate a commercial business in space. This is part of NASAs objective to make orbit more commercial, providing access to space for nearly anyone.

Another complex Techshot-managed experiment launching onboard SpaceX CRS-20 will test whether a heart-specific stem cell, called a cardiac progenitor, multiplies better in space and if more of them become heart muscle cells known as cardiomyocytes. This is part of Chunhui Xu, an associate professor in the department of pediatrics at the Emory University School of Medicine who studies heart cells, research that aims to improve treatments for congenital heart disorders and better the hearts ability to regenerate after injuries.

Preparing the experiments: under the vent hood, Biomedical Engineer Jordan Fite adds media to bags and fluid loops that will be used in the experiment in space (Image: Techshot)

Techshot explained that human cardiac tissues cant repair themselves once damaged from disease, due to this, repairing a failing heart by cell therapy requires a large number of cardiomyocytes, which can be converted from stem cells cultured in two dimensions in Earth-based laboratories. Without the pull of gravity, it is expected that culturing in three dimensions in space, inside specialized Techshot cell culture experiment modules, will increase the yield of high-quality heart muscle cells. The company expects that learning more about why this happens could lead to new strategies for reproducing the same results on a much larger scale on Earth, lowering costs and enabling more patients to receive needed cardiac cell therapies.

Astronaut handling Techshots BFF (Image: Techshot/NASA)

It is expected that once the cargo spacecraft reaches the station, the 12 Techshot experiment modules will be removed from the spacecraft and inserted by the crew into the companys Multi-use Variable-gravity Platform (MVP) unit number two mounted in the Japanese space laboratory known as Kibo.

We are thankful for Techshots engineers who designed the Multi-use Variable-gravity Platform hardware and will help us maintain constant communication with the astronauts during the flight operation. Their professionalism and collaboration with our team have contributed tremendously toward our overall research efforts, said Ho.

Besides the materials for the BFF meniscus print, SpaceX CRS-20 will also carry 12 Passive Orbital Nutrient Delivery System, or PONDS, plant growth devices that Techshot co-developed with Tupperware Brands, and that was first prototyped by NASA Kennedy Space Center. According to company officials, they will be growing red romaine lettuce inthe devices, installed inside two of the space stations identical plant growth chambers each called Veggie. The PONDS units are being tested in two different configurations, each representing approaches refined from two previous flight tests. For this demonstration, lettuce is expected to grow in space for 21 days. Besides the hardware built and own, Techshot also manages the space stations most complex greenhouse, called the Advanced Plant Habitat, and it manages two on-orbit research furnaces called PFMI and SUBSA.

Techshot has been working hard to get samples ready in a lab at the Space Station Processing Facility at NASAs Kennedy Space Center.

Product assurance associate Keri Roeder, program manager Nathan Thomas and mechanical engineer Grant Vellinger prepared samples for Techshot customer Emory University (Image: Techshot)

Founded more than 30 years ago, Techshot operates its own commercial research equipment in space and serves as the manager of three NASA-owned ISS payloads. The company is also working on other space 3D printing technologies. Last fall they tested a laser-based 3D metal printer in zero gravity inside an aircraft performing parabolic arcs over the Gulf of Mexico (sometimes unofficially nicknamed the vomit comet). However, officials suggest that this technology is still at least a couple of years from Techshot launching it to the space station.

NASA and dozens of companies continue to work together to develop the means for astronauts and space explorers to endure life in orbit, the Moon and other planets. This vision is enthralling for anyone who ever dreamed of going to space, even hopeful of the next generations that will be able to experience space travel and conduct research work in microgravity. Perhaps we are too hopeful of the future, but with so much going on, its difficult not to be.

The launch on Friday will be the last SpaceX launch under the current NASA CRS-1 contract, yet SpaceX will continue performing resupply missions under a new CRS-2 contract beginning with the next scheduled resupply mission in August this year. To watch the launch, which is scheduled to take place at 11:50 p.m. EST on Friday, March 6, and capture of the spacecrafts arrival at the ISS, you can tune into NASA TV using the video below:

More here:
Techshots New Projects Will be on the Next SpaceX Mission Launch - 3DPrint.com

Recommendation and review posted by Bethany Smith

Newswise Launching no earlier than March 6 at 11:50 PM EST, the Johns Hopkins University will send heart muscle tissues, contained in a specially-designed tissue chip the size of a small cellphone, up to the microgravity environment of the International Space Station (ISS) for one month of observation.

The project, led by Deok-Ho Kim, an Associate Professor of Biomedical Engineering and Medicine at The Johns Hopkins University and the projects principal investigator, will hopefully shed light on the aging process and adult heart health, and facilitate the development of treatments for heart muscle diseases.

Scientists already know that humans exposed to space experience changes similar to accelerated aging, so we hope the results can help us better understand and someday counteract the aging process, says Kim.

The researchers also hope the study will demystify why astronauts in space have reduced heart function and are more prone to serious irregular heartbeat; these results could help protect astronauts hearts on long missions in the future, as well as provide information on how to combat heart disease.

Kim and his team used human induced pluripotent stem cells to grow cardiomyocytes, or heart muscle cells, in a bioengineered, miniaturized tissue chip that mimics the function of the adult human heart. While other researchers have studied stem cell-derived heart muscle cells in space before, these studies relied on cells cultured on 2D surfaces, or flat planes, that arent representative of how cells exist and behave in the body, and are therefore underdeveloped compared to their counterparts in adult humans.

The teams tissue platform gives the advantage of the cells residing in a 3D environment, which will allow for better imitation of how cell signals and actions develop as they would in the human body. This 3D environment is possible thanks to a new scaffold biomaterial, or support structure which holds the tissues together, that accelerates development of the heart muscle cells within. This will allow the scientists to collect data useful for understanding the adult human body. Scientists could someday use this data and platform to develop new drugs, among many other applications.

Using a motion sensor magnet setup, the team will receive real-time measurements of how the tissues on the ISS beat. After about one month in space, the tissues will return to Earth and will be analyzed for any differences in gene expression and contraction caused by the extended stay in microgravity. Some of these tissues will be cultured for an additional week on Earth for the researchers to examine any recovery effects. The team will also have identical heart tissues on Earth at the University of Washington to serve as controls.

We hope that this project will give us meaningful data that we can use to understand the hearts structure and how it functions, so that we can improve the health of both astronauts and those down here on Earth, says Kim.

"The entire team is excited to see the results we get from this experiment. If successful, we will embark on the second phase of the study where tissues will be sent up to the ISS once again in two years, but this time, we will be able to test a variety of drugs to see which ones will best ameliorate the potentially harmful effects of microgravity on cardiac function," says Jonathan Tsui, a postdoctoral fellow in the Department of Biomedical Engineering at The Johns Hopkins University and a member of Kims lab.

This project is funded by the National Center for Advancing Translational Sciences (NCATS) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) as part of the Tissue Chips in Space initiative in collaboration with the ISS U.S. National Laboratory.

Collaborators on this project include Eun Hyun Ahn of The Johns Hopkins University; Nathan Sniadecki and Alec Smith of The University of Washington; Peter Lee of Ohio State University; and Stefanie Countryman of Bioserve Space Technologies at the University of Colorado Boulder. For space flight the team has worked with BioServe Space Technologies to translate the ground platform into a space flight certified system.

See the article here:
Little Tissue, Big Mission: Beating Heart Tissues to Ride Aboard The ISS - Newswise

Recommendation and review posted by Bethany Smith

Todays businesses call for the highly focused, comprehensive and detail-oriented information about the market so that they get a clear idea about the market landscape. The Autologous Stem Cell And Non-Stem Cell Based Therapies market research report is generated with a combination of detailed industry insights, and use of latest tools and technology. The study of this market research report covers a market attractiveness analysis, wherein each segment is targeted based on its market size, growth rate, and general attractiveness. The Autologous Stem Cell And Non-Stem Cell Based Therapies market research report plays a key role in developing the strategies for sales, advertising, marketing, and promotion.

TheGlobalAutologous Stem Cell and Non-Stem Cell Based Therapies Marketis expected to reach USD113.04 billion by 2025, from USD 87.59 billion in 2017 growing at a CAGR of 3.7% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2015 & 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

For In depth Information Get Sample Copy of this Report @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-autologous-stem-cell-and-non-stem-cell-based-therapies-market&raksh

Some of the major players operating in the global autologous stem cell and non-stem cell based therapies market areAntria (Cro), Bioheart, Brainstorm Cell Therapeutics, Cytori, Dendreon Corporation, Fibrocell, Genesis Biopharma, Georgia Health Sciences University, Neostem, Opexa Therapeutics, Orgenesis, Regenexx, Regeneus, Tengion, Tigenix, Virxsys and many more.

Market Definition:Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market

In autologous stem-cell transplantation persons own undifferentiated cells or stem cells are collected and transplanted back to the person after intensive therapy. These therapies are performed by means of hematopoietic stem cells, in some of the cases cardiac cells are used to fix the damages caused due to heart attacks. The autologous stem cell and non-stem cell based therapies are used in the treatment of various diseases such as neurodegenerative diseases, cardiovascular diseases, cancer and autoimmune diseases, infectious disease.

According to World Health Organization (WHO), cardiovascular disease (CVD) causes more than half of all deaths across the European Region. The disease leads to death or frequently it is caused by AIDS, tuberculosis and malaria combined in Europe. With the prevalence of cancer and diabetes in all age groups globally the need of steam cell based therapies is increasing, according to article published by the US National Library of Medicine National Institutes of Health, it was reported that around 382 million people had diabetes in 2013 and the number is growing at alarming rate which has increased the need to improve treatment and therapies regarding the diseases.

Browse Detailed TOC Herehttps://www.databridgemarketresearch.com/toc/?dbmr=global-autologous-stem-cell-and-non-stem-cell-based-therapies-market&raksh

Market Segmentation:Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market

Competitive Analysis:Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market

The global autologous stem cell and non-stem cell based therapies market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of autologous stem cell and non-stem cell based therapies market for global, Europe, North America, Asia Pacific and South America.

Major Autologous Stem Cell and Non-Stem Cell Based Therapies Market Drivers and Restraints:

Introduction of novel autologous stem cell based therapies in regenerative medicine

Reduction in transplant associated risks

Prevalence of cancer and diabetes in all age groups

High cost of autologous cellular therapies

Lack of skilled professionals

Reasons to Purchase this Report

Customization of the Report:

Speak to Author of the report @https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-autologous-stem-cell-and-non-stem-cell-based-therapies-market&raksh

About Data Bridge Market Research:

Data Bridge Market Researchis a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475Mail:[emailprotected]

Excerpt from:
Autologous Stem Cell And Non-Stem Cell Based Therapies Market 2020-2025 || Leading Players Fibrocell, Genesis Biopharma, Georgia Health Sciences...

Recommendation and review posted by Bethany Smith

Regenerative Medicine Market: Snapshot

Regenerative medicine is a part of translational research in the fields of molecular biology and tissue engineering. This type of medicine involves replacing and regenerating human cells, organs, and tissues with the help of specific processes. Doing this may involve a partial or complete reengineering of human cells so that they start to function normally.

Get Sample Copy of the Report @https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1889

Regenerative medicine also involves the attempts to grow tissues and organs in a laboratory environment, wherein they can be put in a body that cannot heal a particular part. Such implants are mainly preferred to be derived from the patients own tissues and cells, particularly stem cells. Looking at the promising nature of stem cells to heal and regenerative various parts of the body, this field is certainly expected to see a bright future. Doing this can help avoid opting for organ donation, thus saving costs. Some healthcare centers might showcase a shortage of organ donations, and this is where tissues regenerated using patients own cells are highly helpful.

There are several source materials from which regeneration can be facilitated. Extracellular matrix materials are commonly used source substances all over the globe. They are mainly used for reconstructive surgery, chronic wound healing, and orthopedic surgeries. In recent times, these materials have also been used in heart surgeries, specifically aimed at repairing damaged portions.

Cells derived from the umbilical cord also have the potential to be used as source material for bringing about regeneration in a patient. A vast research has also been conducted in this context. Treatment of diabetes, organ failure, and other chronic diseases is highly possible by using cord blood cells. Apart from these cells, Whartons jelly and cord lining have also been shortlisted as possible sources for mesenchymal stem cells. Extensive research has conducted to study how these cells can be used to treat lung diseases, lung injury, leukemia, liver diseases, diabetes, and immunity-based disorders, among others.

Global Regenerative Medicine Market: Overview

The global market for regenerative medicine market is expected to grow at a significant pace throughout the forecast period. The rising preference of patients for personalized medicines and the advancements in technology are estimated to accelerate the growth of the global regenerative medicine market in the next few years. As a result, this market is likely to witness a healthy growth and attract a large number of players in the next few years. The development of novel regenerative medicine is estimated to benefit the key players and supplement the markets growth in the near future.

Global Regenerative Medicine Market: Key Trends

The rising prevalence of chronic diseases and the rising focus on cell therapy products are the key factors that are estimated to fuel the growth of the global regenerative medicine market in the next few years. In addition, the increasing funding by government bodies and development of new and innovative products are anticipated to supplement the growth of the overall market in the next few years.

On the flip side, the ethical challenges in the stem cell research are likely to restrict the growth of the global regenerative medicine market throughout the forecast period. In addition, the stringent regulatory rules and regulations are predicted to impact the approvals of new products, thus hampering the growth of the overall market in the near future.

Global Regenerative Medicine Market: Market Potential

The growing demand for organ transplantation across the globe is anticipated to boost the demand for regenerative medicines in the next few years. In addition, the rapid growth in the geriatric population and the significant rise in the global healthcare expenditure is predicted to encourage the growth of the market. The presence of a strong pipeline is likely to contribute towards the markets growth in the near future.

Global Regenerative Medicine Market: Regional Outlook

In the past few years, North America led the global regenerative medicine market and is likely to remain in the topmost position throughout the forecast period. This region is expected to account for a massive share of the global market, owing to the rising prevalence of cancer, cardiac diseases, and autoimmunity. In addition, the rising demand for regenerative medicines from the U.S. and the rising government funding are some of the other key aspects that are likely to fuel the growth of the North America market in the near future.

Furthermore, Asia Pacific is expected to register a substantial growth rate in the next few years. The high growth of this region can be attributed to the availability of funding for research and the development of research centers. In addition, the increasing contribution from India, China, and Japan is likely to supplement the growth of the market in the near future.

Request TOC of the Report @https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1889

Global Regenerative Medicine Market: Competitive Analysis

The global market for regenerative medicines is extremely fragmented and competitive in nature, thanks to the presence of a large number of players operating in it. In order to gain a competitive edge in the global market, the key players in the market are focusing on technological developments and research and development activities. In addition, the rising number of mergers and acquisitions and collaborations is likely to benefit the prominent players in the market and encourage the overall growth in the next few years.

Some of the key players operating in the regenerative medicine market across the globe areVericel Corporation, Japan Tissue Engineering Co., Ltd., Stryker Corporation, Acelity L.P. Inc. (KCI Licensing), Organogenesis Inc., Medtronic PLC, Cook Biotech Incorporated, Osiris Therapeutics, Inc., Integra Lifesciences Corporation, and Nuvasive, Inc.A large number of players are anticipated to enter the global market throughout the forecast period.

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Excerpt from:
Regenerative Medicine Market Analysis Growth Demand, Key Players, Share Size, and Forecast To 2025 - Monroe Scoop

Recommendation and review posted by Bethany Smith

March 04, 2020 -Massachusetts General Hospital (MGH) is launching a new Preventive Genomics Clinic that will help advance precision medicine and preventive care by leveraging genetic information.

The new clinic will be integrated with the primary care practices at MGH, and will aim to help patients better understand, prevent, and predict disease. MGH chose to establish the genomics clinic after receiving requests from providers and patients for greater use of genetics in clinical care.

We believe DNA testing will be a key piece of routine care in the future, said Amit V. Khera, MD, an MGH cardiologist and co-founder of the new clinic. But, in many cases, our PCPs were unsure which of the available genetic tests were most appropriate for their patients or how best to integrate that information into an individualized screening or treatment plan. Thats why it was so important for us to root ourselves within primary care from the start.

Common reasons for referral to the clinic include requests for interpretation of an existing genetic test result, concern about family history of disease, or an interest in learning about the risks and benefits of testing while still asymptomatic.

Patients meet with a genetic counselor and physician to gather personal and family history information. If patients do decide to proceed with genetic testing, the team reviews testing options, works with the patients health insurance to determine whether it would be covered, and coordinates with the patients care team to make a plan based on test results.

READ MORE: FDA Approvals Advance Precision Medicine, Genomics Treatments

What has been surprising is the majority of the tests weve ordered have been fully covered by medical insurance based on family history or other indications, said Renee Pelletier, lead genetic counselor of the new program. This speaks to the underutilization of appropriate genetic testing for our patients.

For patients who are truly asymptomatic and have no family history of disease, the clinic offers preventive genomics assessments that typically arent covered by insurance. This could include testing for the BRCA1 mutations, which signal very high risk for breast and ovarian cancer, as well as mutations that can lead to high cholesterol levels and risk for early heart attack. In both of these cases, treatment options exist that can help patients overcome these genetic risks.

The team has also launched an eConsult program, which allows any physician to request a review of his or her patients medical record by the Preventive Genomics Clinic. Staff at the clinic can then determine whether genetic testing or a clinic appointment would be beneficial for the patient. Additionally, the team can answer questions about ordering new genetic testing or interpreting prior genetic testing results.

In many cases, we are able to answer a key clinical question just based on review of medical records, said Leland Hull, MD, a primary care physician in the group. For others, we recommend they be seen in our clinic or one of the several subspecialty clinics available at MGH for more detailed evaluation.

In the future, the clinic expects to see patients who learn about high genetic risk from ongoing research studies, including the Partners HealthCare Biobank or the NIH All of Us Research Program. Over the next several years, these programs are expected to perform sequencing of more than 100,000 participants in the Boston area.

READ MORE: New Precision Medicine Program to Study Role of Genomics in Disease

As the healthcare industry has increasingly recognized the important role precision medicine and genomics can play in patient health, more organizations are supporting the integration of genetic testing with routine clinical care.

Recently, a group of stakeholders launched the Institute for Gene Therapies (IGT), which will aim to modernize the US regulatory and reimbursement framework to ensure gene therapies for patients who need them.

The incredible scientific advancements in this space present unique opportunities to directly improve and save the lives of patients suffering from debilitating diseases, said IGT Chairman and former Congressman Erik Paulsen.

This is not some far-off future patients are already benefiting from the first FDA-approved gene therapies. But we need policy to move faster toward this new reality where we can treat the causes of many diseases. The Institute for Gene Therapies and our members believe unique regulatory and reimbursement structures need to be established, novel development pathways need to be embraced and new value-based arrangements need to be tested.

With the launch of the Preventive Genomics Clinic, MGH will help further incorporate novel tests and treatments into everyday healthcare delivery.

Its exciting to know we can now support access to genomics long before disease develops, promoting the best outcomes for our patients, said Heidi Rehm, PhD, chief genomics officer at MGH. Our goal is to build this resource for our own community and collaborate with other hospitals across the country in defining the best models for this new type of preventive clinical care.

Follow this link:
New Genomics Clinic Will Enable Preventive Care, Precision Medicine - HealthITAnalytics.com

Recommendation and review posted by Bethany Smith

ALBANY, New York, March 4, 2020 /PRNewswire/ -- Owing to multiple factors such as adoption of advanced technologies, high demand for well-bred animals with desirable genetic traits (livestock and poultry), and increase in disposable income is helping the global animal genetics marketchart a Compound Annual Growth Rate of 6.0 % from 2018 to 2026. As a result of this robust growth rate, market would be reach a valuation of USD 8.0 bn by the end of the forecast period.

Transparency Market Research states, "One of the most significant trends that will lead to a higher market growth over the forecast period is increase in ownership of companion animals. Besides, with food safety and quality gaining prominence, the live animal segment will show significant growth from 2018 to 2026."

Key Findings of the Animal Genetics Market Study

Explore 157 pages of top-notch research, incisive insights, and detailed country-level projections. Gain business intelligence on Animal Genetics market by Product Type - Live Animals (Bovine, Porcine, Poultry, Canine, and Piscine), Genetic Material (Semen, Embryo), Genetic Testing, Read Details TOC of the Report - https://www.transparencymarketresearch.com/report-toc/18995

Animal Genetics Market: Key Driving Factors

The animal genetics market is set to witness sturdy growth over the forecast period owing to a plethora of trends and growth drivers. As per Transparency Market Research, some of the crucial factors are high level of consumption of meat and poultry products, increase in purchasing power of people, need to plug supply gaps in terms of food, and growing demand for stronger animals, well-bred and with desirable genetic traits. An overview of growth factors is provided below:

Request PDF Brochure of Animal Genetics Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18995

Key Impediments for Animal Genetics Market Players

Despite charting a steady growth curve over the forecast period, the global animal genetics market would not be free from restraints. As per Transparency Market Research, one of the major restraints that will limit growth in the global animal genetics market is the regulatory environment which is strict in terms of animal genetic engineering. Besides, a notable dearth of skilled professionals in the market is also a limiting factor in the global animal genetics market. Additionally, it is worth noting that animal testing is expensive.

Animal Genetics Market: Region-wise Analysis

Analyze Animal Genetics market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea. Request a sampleof the study,

Competition Landscape

Research and Development (R&D) forms the core of global animal genetics market and is thus a major determinant of the size of market share a player holds. Besides, players also forge partnerships in order to tap into uncharted territories in order to bring a larger consumer base into the fold. It is pertinent to note here that technology also holds a prominent place in the market.

Transparency Market Research has profiled key players such as Genus plc, CRV Holding B.V., Neogen Corporation Zoetis, Inc., Groupe Grimaud, Topigs Norsvin, VetGen, Animal Genetics Inc., and Hendrix Genetics BV, in its market report. The global animal genetics market has a decent number of players operating the market landscape.

Transparency Market Research has segmented the Animal Genetics market report based on product type, geography and forecast.

Product Type:

Explore Transparency Market Research's award-winning coverage of the Global Healthcare Industry:

Thyroid Function Test Market: The global thyroid function test market was valued at approximately US$ 1.3 Bn in 2018. It is anticipated to exceed a value of US$ 2.4 Bn by 2027, expanding at a CAGR of more than 5% from 2019 to 2027. The global market is driven by an increase in the incidence of thyroid disease, rise in geriatric population, increase in obese, diabetic, and cardiovascular patients, and increase in disease awareness programs in developing regions.

DNA Test Kits Market: The global DNA test kits market is driven by increase in the number of direct to consumer genetic testing companies offering DNA tests for ancestry and health & fitness, rise in focus on health risk & preventive care, and increase in demand for ancestry DNA testing services across the globe.

Audiological Devices Market: The global audiological devices market was valued at about US$ 8.7 Bn in 2017 and is expected to reach a value of US$ 13.4 Bn by 2026, expanding at a compound annual growth rate (CAGR) of over 5.0% from 2018 to 2026. The global market is witnessing expansion at a relatively higher growth rate owing to the increasing geriatric population, adoption of audiological devices due to rising number of cases of hearing loss, and surge in research and development in both developed and developing markets.

Laser Capture Microdissection Market: Increasing expenditure on healthcare along with technological advancement in the field of healthcare is one of the major driving factors for the laser capture microdissection market. Furthermore, increasing information regarding the technical advantages obtained from laser-capture microdissection techniques is fueling the market at the global level.

Gain access to Market Ngage, an AI-powered, real-time business intelligence that goes beyond the archaic research solutions to solve the complex strategy challenges that organizations face today. With over 15,000+ global and country-wise reports across 50,000+ application areas, Market Ngage is your tool for research on-the-go. From tracking new investment avenues to keeping a track of your competitor's moves, Market Ngage provides you with all the essential information to up your strategic game. Power your business with Market Ngage's actionable insights and remove the guesswork in making colossal decisions.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key tohelp enterprises reach right decision."

Contact

Transparency Market ResearchState Tower,90 State Street,Suite 700,Albany NY - 12207United StatesUSA - Canada Toll Free: 866-552-3453Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

View original content:http://www.prnewswire.com/news-releases/demand-for-well-bred-animals-with-desirable-genetic-traits-to-drive-animal-genetics-market-transparency-market-research-301016136.html

SOURCE Transparency Market Research

Go here to read the rest:
Demand for Well-bred Animals With Desirable Genetic Traits to Drive Animal Genetics Market: Transparency Market Research - Benzinga

Recommendation and review posted by Bethany Smith

FT. MYERS, FL / ACCESSWIRE / March 2, 2020 / NeoGenomics, Inc. (NEO), a leading provider of cancer-focused genetic testing services, announced today that the company has been awarded a three-year contract with HealthTrust Purchasing Group (HPG). Effective March 1, 2020, NeoGenomics will serve as the cornerstone laboratory for HPG's Specialized Reference Laboratory for Oncology & Cancer Genetics, a newly-created category for oncology diagnostics in personalized medicine.

"We are honored to be awarded this contract to provide our testing services for all HPG-affiliated hospitals, cancer centers, pathology groups, and oncology/physician providers nationwide," said Douglas M. VanOort, Chairman and CEO, NeoGenomics. "This agreement gives NeoGenomics the distinction of being the first specialized oncology laboratory to become a preferred in-network lab option to help HPG members diagnose and treat cancer."

The agreement secures standardized corporate pricing for all HPG-affiliated facilities and health care providers nationwide, and it provides access to the extensive portfolio of NeoGenomics' cancer diagnostic and oncology genetics testing services and emerging informatics solutions.

About NeoGenomics, Inc.

NeoGenomics, Inc. specializes in cancer genetics testing and information services. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company's Pharma Services Division serves pharmaceutical clients in clinical trials and drug development.

Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA certified laboratories in Ft. Myers and Tampa, Florida; Aliso Viejo, Carlsbad, Fresno and San Diego California; Houston, Texas; Atlanta, Georgia; Nashville, Tennessee; and CAP accredited laboratories in Rolle, Switzerland, and Singapore. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and pharmaceutical firms in Europe and Asia. For additional information about NeoGenomics, visit http://www.neogenomics.com/.

About HealthTrust

HealthTrust (HealthTrust Purchasing Group, L.P.) is committed to strengthening provider performance and clinical excellence through an aligned membership model and the delivery of total spend management advisory solutions that leverage operator experience, scale and innovation. Headquartered in Nashville, Tennessee, HealthTrust (www.healthtrustpg.com) serves over 1,600 hospitals and health systems, and more than 43,000 other member locations including ambulatory surgery centers, physician practices, long-term care and alternate care sites. Twitter @healthtrustpg.

Forward Looking Statements

Certain information contained in this press release constitutes forward-looking statements for purposes of the safe harbor provisions of The Private Securities Litigation Reform Act of 1995. These forward looking statements involve a number of risks and uncertainties that could cause actual future results to differ materially from those anticipated in the forward-looking statements as the result of the Company's ability to continue gaining new customers, offer new types of tests, integrate its acquisition of the Genoptix business and otherwise implement its business plan, as well as additional factors discussed under the heading "Risk Factors" and elsewhere in the Company's Annual Report on Form 10-K filed with the SEC on February 26, 2019, amended by a 10K/A filed with the SEC on May 8, 2019. As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. In addition, it is the Company's practice to make information about the Company available by posting copies of its Company Overview Presentation from time to time on the Investor Relations section of its website at http://ir.neogenomics.com/.

Forward-looking statements represent the Company's estimates only as of the date such statements are made (unless another date is indicated) and should not be relied upon as representing the Company's estimates as of any subsequent date. While the Company may elect to update forward-looking statements at some point in the future, it specifically disclaims any obligation to do so, even if its estimates change.

Story continues

See more here:
NeoGenomics Announces Three-Year Contract to be Cornerstone Oncology and Cancer Testing Laboratory for Large, National Group Purchasing Organization -...

Recommendation and review posted by Bethany Smith

With the effectual use of technology, innovative applications and expertise, this Direct-to-Consumer (DTC) Genetic Testing Market analysis report has been generated which successfully manages bulky and complex market data tables. To give clear idea about the current and future marketplace, most up to date market insights and analysis has been offered via this report. Several critical market factors covered in this Direct-to-Consumer (DTC) Genetic Testing Market report consist of primary research, benchmarking studies, secondary research, company profiles, competitive intelligence & reporting, syndicated research, data collection, data processing and analysis, survey design, and survey programming. Market analysis report execution is becoming very central for the businesses to gain success because it offers insights into revenue growth and sustainability initiative.

Competitive Analysis:The key players are highly focusing innovation in production technologies to improve efficiency and shelf life. The best long-term growth opportunities for this sector can be captured by ensuring ongoing process improvements and financial flexibility to invest in the optimal strategies. Company profile section of players such as EasyDNA, Ancestry, 23andMe Inc., Color Genomics, Inc., Genesis HealthCare, Full Genomes Corporation, Inc., Helix OpCo LLC, IDENTIGENE, LLC, Living DNA Ltd, Mapmygenome, Pathway Genomics, Gene by Gene, Ltd., MyHeritage Ltd., 10X Genomics, Dante Labs, Inc., 24Genetics, LabCorp, Myriad Genetics, Inc., Quest Diagnostics Incorporated, Abacus Diagnostica Oy among others.

Direct-to-Consumer (DTC) Genetic Testing Market Overview 2020-2026: Direct-to-consumer genetic testing are those tests which are promoted straight to customers through different modes such as advertisements, television or internet. Customers send their DNA samples to the company so they can run vital tests and prepare the customers report accordingly which could be available on the secure website or in written format. Direct-to-consumer genetic analysis offers people with easy access to their genetic facts and figures without needing any health insurance company or healthcare provider.

Browse Complete Report Details with Table of Content and Figures @https://www.databridgemarketresearch.com/toc/?dbmr=global-direct-to-consumer-dtc-genetic-testing-market

Market Driverso High ageing population and growing prevalence of genetic diseases will boost this market growtho Growing customer awareness about the DTC genetic testing acts as a market drivero Tests are effortlessly accessible to the customers around the world; this factor acts as a major market drivero Usage of DTC in genetic testing helps in the early disease detection and identification of genetic disorder which augments the demand of this marketMarket Restraintso High charges of DTC genetic testing kits can hamper the growth of this marketo Lack of skilled and trained professional is another factor restraining the growth of the marketo Scientific, technical and clinical issues along with fidelity to facts and truth-in-advertising can also act as restraining factor for the growth of this market

Highlights of the Report

o The report offers a 360-degree overview of the Direct-to-Consumer (DTC) Genetic Testing Market, primarily emphasizing on growth drivers, restraints, market trends, size, share, growth, challenges, new recent developments and opportunities of the market.

o It provides elaborative information about the competitive landscape of the market, names of market vendors, market segmentation on the basis of application, type, and others, and current logging-while-drilling market trends and industry developments.

o The report also throws light on strategies such as company collaborations, mergers and acquisitions, production analysis, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations and up-gradation of the older versions, investments in research and development, and other strategies adopted by the market players.

List of the Leading Companies that are operating in the global Direct-to-Consumer (DTC) Genetic Testing Market are: EasyDNA, Ancestry, 23andMe Inc., Color Genomics, Inc., Genesis HealthCare, Full Genomes Corporation, Inc., Helix OpCo LLC, IDENTIGENE, LLC, Living DNA Ltd, Mapmygenome, Pathway Genomics, Gene by Gene, Ltd., MyHeritage Ltd., 10X Genomics, Dante Labs, Inc., 24Genetics, LabCorp, Myriad Genetics, Inc., Quest Diagnostics Incorporated, Abacus Diagnostica Oy among others.Direct-to-Consumer (DTC) Genetic Testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipments, installed base of different kind of products for Direct-to-Consumer (DTC) Genetic Testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Direct-to-Consumer (DTC) Genetic Testing market. The data is available for historic period 2010 to 2018.

For More Information or Query or Customization Before Buying, Visit @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-direct-to-consumer-dtc-genetic-testing-market

The Direct-to-Consumer (DTC) Genetic Testing Market report highlights the key players and the latest strategies including company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, new product launches, partnerships, joint ventures, product width and breadth, application dominance, technology lifeline curve, segmentation in terms of region and industry competition, profit and loss ratio, and investment ideas.

Global Direct-to-Consumer (DTC) Genetic Testing Market In-depth Segmentation:

By Service (Diagnostic Screening, Prenatal, Newborn Screening, Pre-Implantation Diagnosis, Relationship Testing), Test Type (Carrier Testing, Predictive Testing, Ancestry & Relationship Testing, Nutrigenomics Testing, Others)

By Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips, Whole Genome Sequencing (WGS)

By Product Type (Ancestry, Health and Wellness, Entertainment), Business Model (Genome Data Bank Material Model, Individual Health Planning Model, Comprehensive Genome Tests Model, Medical Precision Tests Model, Restricted Trait Tests Model)

By End User (Laboratories, Blood Banks, Nursing Homes, Hospitals, Imaging Centers, Home Care, Cosmetics, Others), Sales Channel (Online Sales, OTC Sales, Doctors Office)

By Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa)

Global Direct-to-Consumer (DTC) Genetic Testing Market reports provides 5 year pre-historic and forecast for the sector and include data on socio-economic data of global. Key stakeholders can consider statistics, tables & figures mentioned in this report for strategic planning which lead to success of the organization.

The Direct-to-Consumer (DTC) Genetic Testing report has been produced with the systematic gathering and analysis of information about individuals or organizations conducted through social and opinion research. With the studies, insights and analysis mentioned in the report, you get comprehensible idea about the marketplace with which you can take business decisions quickly and easily. The worldwide Direct-to-Consumer (DTC) Genetic Testing advertise report comprises of all the organization profiles of the key players and brands. Market definition covered in this Direct-to-Consumer (DTC) Genetic Testing report studies the market drivers and market restraints with which businesses can get idea of whether to increase or decrease the production of a particular product.

Global Direct-to-Consumer (DTC) Genetic Testing Market Report includes Major Detailed Table of Content Points: Table of Content

1 Introduction2Market Segmentation3 Market Overview4 Executive Summaries5 Premium Insights6 Regulatory Procedure7 Global Direct-to-Consumer (DTC) Genetic Testing Market, By Type8 Global Direct-to-Consumer (DTC) Genetic Testing Market, by disease type9 Global Direct-to-Consumer (DTC) Genetic Testing Market, By Deployment10 Global Direct-to-Consumer (DTC) Genetic Testing Market, By End User11 Global Direct-to-Consumer (DTC) Genetic Testing Market, By Distribution Channel12 Global Direct-to-Consumer (DTC) Genetic Testing Market, By Geography13 Global Direct-to-Consumer (DTC) Genetic Testing Market, Company Landscape14 Company Profile

Continued!!!

Contact Us:

Data Bridge Market ResearchUS: +1 888 387 2818UK: +44 208 089 1725Hong Kong: +852 8192 7475Email: [emailprotected]

Go here to see the original:
Direct-to-Consumer (DTC) Genetic Testing Market Outlook: Investors Still Miss the Big Assessment| EasyDNA, Ancestry, 23andMe, Color Genomics, Genesis...

Recommendation and review posted by Bethany Smith

Washington's Democratic senator made it clear Tuesday that she isn't impressed by Trump's response to the crisis. C-SPAN

The administration has had months to prepare for this andif someone in the White House is actually in charge of responding to this crisis it would be news to anyone in my state, Murray said. This is really a frightening time. At least six people in my home state have already died from the virus and Im told we should expect more.

Tuesdays Senate hearing included bipartisan criticism of the federal governments handling of the crisis, particularly the way the Centers for Disease Control (CDC) fumbled the distribution of testing kits for the new coronavirus, which is technically referred to as SARS-CoV-2. The CDCs initial testing kits were found to be defective and the agency has only tested a few hundred people for the virus, according to data that was abruptly removed from the agencys website yesterday.

Senators during Tuesday's hearing repeatedly focused on a deadly outbreak at a long-term care facility in Kirkland. Sen. Richard Burr, a Republican from North Carolina, asked the CDCs principal director how the outbreak could have happened given the CDC knew that the virus was present in Washington state.

How can we have a situation like Washington state where we have known for up to six weeks, [with the virus] reaching possibly 1,500 individuals, yet we experienced what we have with this long term care facility how can that happen when we invested so much in being there early on? Burr said.

Dr. Anne Schuchat, the principal director of the CDC, did not specifically explain why testing was not broadened in Washington but said that the outbreak in Kirkland was tragic.

The situation in Washington state is tragic, Schuchat said. An outbreak in a long-term care facility is one of the things we have been worried about since day one.

Dr. Stephen Hahn, a commissioner with the Food and Drug Administration (FDA), testified that the FDA is working with a private diagnostic test manufacturer to distribute 2,500 test kits able to complete 500 tests each, or over one million tests cumulatively, by the end of the week. Hahn was pressed by multiple Senators as to why he was confident that suddenly so many tests would be available when the government has so far struggled to get even a few hundred people tested. He offered a mild guarantee, saying that we have been in touch with this particular manufacturer over the last few days and we know them well.

But a report from The New York Times following Tuesday's hearing cast doubt on the government's ability to meet Hahn's prediction of one million tests by the end of the week.

Asked whether the government will have enough diagnostic tests to handle the outbreak, Schuchat said she was optimistic, but I want to remain humbled."

The CDC first distributed diagnostic tests around the country in February, but those tests were defective and unable to be used. The CDC eventually released a fix to the flawed kits, but that remedy was only sent to a small number of labs across the country, according to the New York Times.

The CDC also continued to use a restrictive set of criteria for who could receive the test, allowing people to be tested only if they had recently traveled to China or if they came in contact with a confirmed case of the new virus. That criteria was widened late last week to include travelers from affected areas other than China and for people who were hospitalized with unexplained flu-like symptoms.

The Food and Drug Administration further expanded testing on Saturday by allowing labs to do testing on their own, using their own diagnostic tests, instead of waiting for the CDC to provide replacements.

But the overall delay in testing has been blamed for hastening the spread of the deadly virus, particularly in the Seattle area. Genetic testing of two COVID-19 cases in Washington showed evidence the virus has been spreading in the Seattle region unnoticed for six weeks, according to genetic testing conducted by the Fred Hutchinson Cancer Research Center in Seattle.

Trevor Bedford, a researcher with Fred Hutchinson, has posted data supporting this hypothesis online and has blamed a lack of testing for accelerating the spread of the virus.

This lack of testing was a critical error and allowed an outbreak in Snohomish County and surroundings to grow to a sizable problem before it was even detected, Bedford said in a blog posted Monday.

More:
Patty Murray Grills Trump Administration Over Seattle's Coronavirus Outbreak: This Is A Really Frightening Time - TheStranger.com

Recommendation and review posted by Bethany Smith

The latest Genetic Testing Services market study offers an all-inclusive analysis of the major strategies, corporate models, and market shares of the most noticeable players in this market. The study offers a thorough analysis of the key persuading factors, market figures in terms of revenues, segmental data, regional data, and country-wise data. This study can be described as most wide-ranging documentation that comprises all the aspects of the evolving Genetic Testing Services market.

The research report provides deep insights into the global market revenue, parent market trends, macro-economic indicators, and governing factors, along with market attractiveness per market segment. The report provides an overview of the growth rate of Genetic Testing Services market during the forecast period, i.e., 20202027. Most importantly, the report further identifies the qualitative impact of various market factors on market segments and geographies. The research segments the market on the basis of product type, application, technology, and region. To offer more clarity regarding the industry, the report takes a closer look at the current status of various factors including but not limited to supply chain management, niche markets, distribution channel, trade, supply, and demand and production capability across different countries.

To get sample Copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPHE100001383/

The Genetic Testing Service market was valued at US$ 9,546.2 million in 2019 and is expected to grow at a CAGR of 11.7% from 2020 to 2027 to reach US$22,701.8million by 2027.

Market Insights

Government initiatives to increase awareness in the European Region

In Europe, Genetic testing has been growing at an exceptional rate; a large panel of tests are now offered to screen a number of genetic diseases. Treatments are available for a number of rare genetic diseases, and the process is gaining importance in scenarios, such as carrier testing, newborn screening, predictive, and pre-symptomatic testing, among others. Moreover, European countries have undertaken a number of initiatives to increase awareness among people about the benefits of genetic testing. For instance, EuroGentest is a project funded by the European Commission to harmonize the process of genetic testing, from sampling to counseling, across Europe. The ultimate goal is to ensure that all aspects of genetic testing are of high quality, thereby providing accurate and reliable results for the benefit of the patients. In addition, the UK Genetic Testing Network (UKGTN), an advisory organization in UK, promotes equity of access to genetic testing and provides contracting support to the NHS

Type Insights

The global genetic testing service market, based on the type, has been segmented into predictive testing, carrier testing, prenatal testing, newborn screening and others. In 2019, the predictive testing segment accounted for the largest market share in the global genetic testing service market by disease. Genetic Testing Services consist of large panel of tests are now offered to screen a number of genetic diseases. Treatments are available for a number of rare genetic diseases, and the process is gaining importance in scenarios, such as carrier testing, newborn screening, predictive, and pre-symptomatic testing, among others.

Key Players

The research provides answers to the following key questions:

The study conducts SWOT analysis to evaluate strengths and weaknesses of the key players in the Genetic Testing Services market. Further, the report conducts an intricate examination of drivers and restraints operating in the market. The report also evaluates the trends observed in the parent market, along with the macro-economic indicators, prevailing factors, and market appeal according to different segments. The report also predicts the influence of different industry aspects on the Genetic Testing Services market segments and regions.

Our reports will help clients solve the following issues:

Insecurity about the future:

Our research and insights help our clients anticipate upcoming revenue compartments and growth ranges. This will help our clients invest or divest their assets.

Understanding market opinions:

It is extremely vital to have an impartial understanding of market opinions for a strategy. Our insights provide a keen view on the market sentiment. We keep this reconnaissance by engaging with Key Opinion Leaders of a value chain of each industry we track.

Understanding the most reliable investment centers:

Our research ranks investment centers of market by considering their future demands, returns, and profit margins. Our clients can focus on most prominent investment centers by procuring our market research.

Evaluating potential business partners:

Our research and insights help our clients identify compatible business partners.

Interested in purchasing this Report? Click here @ https://www.theinsightpartners.com/buy/TIPHE100001383/

Genetic Testing Services Market Segmented by Region/Country: North America, Europe, Asia Pacific, Middle East & Africa, and Central & South America

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.

We understand syndicated reports may not meet precise research requirements of all our clients. We offer our clients multiple ways to customize research as per their specific needs and budget

Contact Us:

The Insight Partners,

Phone: +1-646-491-9876

Email: [emailprotected]

Continued here:
Genetic Testing Services Market Insight on the Analysis by Essential Factors and Trends In Industry by 2027 - Jewish Life News

Recommendation and review posted by Bethany Smith

AUSTIN, Texas, March 04, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (VRML), a bioanalytical-based womens health company focused on gynecologic disease, today announced Valerie Palmieri will participate on a Women in Leadership Panel, representing the corporate sector, at Women and Girls Day at the Connecticut State Capital. The all-day event is in celebration of Womens History Month and the 100thanniversary of womens suffrage. The company will also have an education booth on site for OVA1 Plus and overall Ovarian Cancer Awareness.

The event, hosted by the State of Connecticut, will be moderated by Melissa McCaw, Secretary of the Office of Policy and Management for the State of Connecticut and will feature topics critical to womens health. Other participants in the panel include: Susan Bysiewicz, Lieutenant Governor for the State of Connecticut; Dr. Elsa Nez, President of Eastern Connecticut State University; and Fran Pastore, CEO and Founder of Womens Business Development Council.

We are very honored to participate in this prestigious event and to be recognized by the Governor and Lt. Governor from the State of Connecticut for our commitment to womens health, said Valerie Palmieri, CEO of Vermillion, Inc.

About Vermillion, Inc.Vermillion, Inc. is transforming womens health with the discovery, development and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1plus combines our FDA-cleared products OVA1 and OVERA to detect risk of ovarian malignancy in women with adnexal masses. Recently launched, ASPiRA GenetiXSM testing offers both targeted and comprehensive genetic testing options with a gynecologic focus. With over 10 years of expertise in ovarian cancer risk assessment Vermillion has expertise in cutting-edge research to inform our next generation of products. Our focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection and optimize treatment plans. Visit our website for more information about our products at http://www.vermillion.com.

Investor Relations Contact:Ashley R. RobinsonLifeSci Advisors, LLCTel 617-775-5956Arr@LifeSciAdvisors.com

The rest is here:
Vermillion to Participate in Statewide Women and Girls Day at the Connecticut State Capital on March 6, 2020 - Yahoo Finance

Recommendation and review posted by Bethany Smith

Reasons why you're gaining weight out of nowhere

Its understandable when you gain a few pounds after a vacation or if you break your ankle and spend six weeks propped on the couch binge watching cooking shows (and the sweets to go with them).

But when you can't zip your jeans for no reason at all you swear youre not eating any more or exercising any less it can feel like theres some dark magic at play. You may find yourself standing on the bathroom scale, screaming into the void:

Most likely, theres something in your life thats shifted just enough to make a difference, but not so much that youd notice, says Dr. Alexandra Sowa, an obesity specialist and clinical instructor of medicine at NYU Langone Health. I see this all the time. You may not step on the scale for a while, and you feel like you havent changed anything, and all of a sudden you go to the doctors office and notice youve gained 10 or 20 pounds, she says.

But that doesnt mean its your destiny to go up another size every year. Here are some of the most likely reasons for unexplained weight gain, and how to stop it in its tracks.

If youve been battling weight issues for a while and none of your efforts are moving the needle, make an appointment with your primary care doctor or a weight-management physician, who can assess you for insulin resistance or prediabetes. Your doctor can also test you for hypothyroidism, in which your thyroid gland doesnt produce enough hormone, slowing down your metabolism and potentially leading to weight gain.

Insulin is the hormone that signals the body to pull glucose out of the bloodstream and store it in the muscles, liver and fat, explains Dr. Tirissa Reid, an obesity medicine specialist at Columbia University Medical Center and Diplomate of the American Board of Obesity Medicine. But when youre overweight, the cells dont recognize the insulin as well, so the pancreas has to pump out more and more sometimes two or three times the normal amount until the cells respond. This is also common in women who have polycystic ovary syndrom, a condition in which the egg follicles in the ovaries bunch together to form cysts.

These high insulin levels keep the body in storage mode and make weight loss more difficult, says Dr. Reid. The beginning of this road is insulin resistance when your pancreas is working overtime, but blood sugar levels are still normal. All that extra work wears out the pancreas until it can barely do the job of keeping the blood sugar in normal range. Left unchecked, insulin resistance can lead to prediabetes, in which blood-sugar levels are slightly elevated; if thats not treated, you can develop full-blown type-2 diabetes.

What you can do: The most effective way to reverse this trend is to eat a diet low in refined carbs and added sugars, and to become more physically active, since muscles respond better to insulin after exercise, says Dr. Reid.

She recommends either investing in a fitness tracker or simply using the one that comes with your phone. People hear you need 10,000 steps each day, which sounds intimidating, but you can also use it just to see where youre at and make doable increases, Dr. Reid says. If youre at 2,000 steps, try to go up to 2,500 a day next week and continue to increase. Swapping to foods with a lower glycemic index (GI) which means theyre digested more slowly, keeping blood-sugar levels steady is also important for controlling your insulin levels. Dr. Sowa recommends these lower-GI food swaps: riced cauliflower instead of white rice; zucchini spirals or shirataki noodles (made from plant fiber) instead of pasta; and pumpernickel or stone-ground whole wheat bread instead of white bread or bagels.

If youre up at night worrying about your aging parents or your kids, this can affect your metabolism. Stress and lack of sleep can cause a cascade of hormonal changes that change your metabolism and affect your sense of hunger and fullness, Dr. Sowa explains.

Stress pumps up the hormones ghrelin and cortisol, which increase your appetite and can make you crave carbs; at the same time, it dials down the hormone leptin, which helps you feel full. Not surprisingly, a 2018 Swedish study of 3,872 women over 20 years found the more stressed you are by work, the more likely you are to gain weight. Stress also affects your ability to get a good nights sleep, and we know that lack of sleep can also throw off your metabolism rates and hunger cues.

What you can do: You can manage your stress by downloading an app such that helps you work toward personal goals such as thinking positively and decreasing anxiety by sending you meditations and visualizations to do throughout the day. To sleep more soundly, you already know you should put down your phone, computer and iPad an hour before bedtime, but research shows that shutting out all light including that sliver of moon through your window can help with both sleep and metabolism. A study at Northwestern University Feinberg School of Medicine found that after subjects spent just one night of sleeping in a room with dim light, insulin levels the next morning were significantly higher than those who slept in complete darkness, potentially affecting metabolism rates. So consider investing in some good blackout curtains.

Were not 100% sure why, but its believed that histamines, chemicals produced by your immune system to fight allergens, have a role in appetite control, says Dr. Reid. That means that antihistamines may cause you to eat more, she says. A study from Yale University confirmed that there is a correlation between regular prescription antihistamine use and obesity. Dr. Reid points out that some antihistamines such as Benadryl also cause drowsiness, which could make you less apt to exercise.

What you can do: If you suffer from seasonal allergies and are constantly taking antihistamines, talk to your allergist about alternative treatments such as nasal steroid sprays, nasal antihistamines (which have less absorption into the bloodstream, and therefore less effect on hunger), leukotriene inhibitors such as Singulair or allergy shots, suggests Dr. Jeffrey Demain, founder of the Allergy Asthma and Immunology Center of Alaska. He also says that managing your environment using a HEPA filter, washing your sheets frequently in hot water and keeping pets out of your bedroom can help reduce the need for allergy medication. While youre at it, do an inventory of any prescription medications youre taking that are known to cause weight gain (including certain antidepressants, beta blockers, corticosteroids and the birth control shot) and discuss with your doctor if there are equally effective alternatives that dont affect weight, says Dr. Reid.

Anyone whos ever sat in a vinyl booth staring down a big bowl of pasta knows that portion sizes in America are large. But research from the University of Liverpool published in 2018 found after being served large-size meals outside the home, people tend to serve themselves larger portions up to a week later, meaning supersizing appears to be normalized, says Dr. Lisa R. Young, author of Finally Full, Finally Slim.

Here's what to do: First, Young suggests you spend a few days getting a reality check on how much food youre actually eating at each meal. When you pour the cereal in the bowl in the morning, pour it back into a measuring cup. What you thought was one cup might actually be three cups, especially if youre using a large bowl, she says.

Also, instead of relying on a government agency (or the chef at your favorite restaurant) at to tell you how much to eat, learn to listen to your own body, says Young. Serve yourself just one modest portion on a small plate, and when youre done, wait 20 minutes, she says. It takes that long for the hormones in your belly to reach your brain and tell it youre full. If you get to 20 minutes and your stomach is grumbling, have a few more bites.

Lets say you switched jobs recently, and dinner is now at 9 p.m. instead of 6:30. Or your new habit of streaming Neflix until the wee hours also involves snacking well past midnight. Even if youre not eating more, per se, this change might account for the extra pounds.

Theres a delicate balance between your circadian rhythm (the way your body and brain respond to the daily cues of daylight and darkness) and your calorie intake. That can mean that same sandwich that you eat at lunchtime may actually cause more of a weight gain when eaten at night. A 2017 study at Brigham and Womens Hospital found when college students ate food closer to their bedtime and therefore closer to when the sleep-inducing hormone melatonin was released they had higher percentages of body fat and a higher body-mass index. The researchers theorize this is because the amount of energy your body uses to digest and metabolize food drops as your inner clock tells it to get ready to snooze.

What you can do: There are a few life hacks to keep the late-night snacking to a minimum. Dr. Sowa suggests you commit to writing down every bite you eat after dinner: Whether its on a sticky pad or on an app, keeping track of what youre eating, how much youre eating and how youre feeling when you eat it will hold you accountable for the calories, and it will also help you figure out if youre truly hungry or just bored, she says. She also suggests capping off your evening meal with a brain-and-heart-healthy tablespoon of fish oil. Its a healthy fat that coats your stomach and makes you feel less hungry later, she says.

Each birthday you celebrate brings on one undeniable change: your basal resting metabolism (the rate at which your body at rest burns the energy you take in from food) slows down. Its not a dramatic drop, says Dr. Cheskin. But as you age, youre probably also getting less active and more tired, and your body tends to lose muscle mass, which burns calories more efficiently than fat. So even if youre eating the exact same amount of food as you did when you were younger, your body is simply not burning it off as effectively as it did during the glory days of your 20s.

Here's what to do: You can only budge your BMR a little, but there are a few things you can do to make the math work in your favor. The first is to build up your calorie-burning muscle, says fitness expert Dr. Michele Olson, a professor of sports science and physical education at Huntingdon College. Keep up cardio three times a week for 30 minutes, but add challenging weight training on top of that, she says.

Another metabolism-boosting strategy: Replace some of the carbohydrates in your diet with proteins, which take more energy to digest, therefore burning off more calories through diet-induced thermogenesis, as well as making you feel fuller for longer. Dr. Sowa suggests you eat about 100 grams of protein over the course of the day, filling your plate with lean chicken, fish, shrimp or plant-based proteins such as garbanzo beans, tempeh and edamame, to give your meals more metabolism bang for your buck. This may only add up to a weight loss of a few pounds per year, but combined with exercise, the cumulative effect can be significant, says Dr. Sowa.

Read more here:
Reasons why you're gaining weight out of nowhere - The Advocate

Recommendation and review posted by Bethany Smith